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 Abstract  
 “Door to balloon time, the efficiency of Primary PCI system – Where do we 
stand?  - A large tertiary care hospital experience from India” 
BACKGROUND/AIM:  To determine the DTB in acute STEMI patients and to determine 
the causes for the delay in achieving DTB to ≤ 90 minutes, Clinical and angiographic profile 
of these patients with their outcomes within 30 days of STEMI. 
METHODS:  Ninety-six patients, who underwent primary PCI during Dec 2012 to Nov 
2013, were divided into 2 groups based on their presentation to Cardiology department direct 
{CPU group} or indirect {Casualty group}. We assessed the time taken from door-to-balloon 
which was divided into 7 stages in both the groups and additional casualty delay in the 
patients who presented to emergency department [casualty group]. The primary aim of the 
study was to calculate Door to Balloon time at our centre and to determine the causes for 
delay in DTB in those patients who had DTB > 90 minutes.  
RESULTS:  The mean DTB for overall study patients was 98.1minutes (SD=30.5 min) 
[mean DTB was 84.9 minutes (SD=22.1min) in CPU group in compared to 123.4 minutes 
(SD=28.5 min) in Casualty group with p value of <0.001]. The DTB time ≤ 90 min was 
observed in 66.7% and 12.1 % in CPU and casualty group respectively. Multivariate 
analysis of time variables shown that ECG time, decision and finance arrangement, and 
vascular access time were predictors which delayed DTB > 90 minutes. The most common 
cause of delay in DTB in overall  patients were late finance arrangement and casualty delay 
which were seen in 41.8% and 34.8% patients respectively.[ In the CPU group, the most 
common causes were late finance arrangement and procedural delay whereas in casualty 
group the most common causes were casualty delay and late finance arrangement]. DTB did 
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not differ in patients with mode of payment or their timing [day-time or night-time] but there 
was trend towards higher DTB if the patients presented on weekdays [P value0.086]. Overall 
most common MI in our study was anterior wall MI; most of the patients had only Single 
vessel CAD [most common Culprit artery was LAD/Diagonal]; radial access was the access 
site of choice in 85.4% patients; 83.3 % patients had thrombectomy; stent deployment was 
observed in 90.6% patients; TIMI flow had improved significantly in most of the patients 
(92.7%) after PCI. Overall 30 day mortality and MACCE in our study was observed in 
6.25% & 8.3% patients, respectively. 
[Total 6 deaths - 4 were in-hospital deaths and 2 deaths due to sub-acute stent thrombosis 
within 30days follow up; one patient had ischemic stroke and another patient had 
recurrence of CHF within 30 days follow up] 
Conclusion: The presentation of acute STEMI patients to emergency department, 
significantly delayed DTB when compared with admission to CPU. Apart from casualty 
delay the other causes for delay in DTB were-delay due to late financial arrangement, and 
hemodynamic instability and busy Cath lab and procedural delay. Majority [87.5%] of the 
MACCE occurred in DTB > 90 minutes patients. 
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Introduction 
Cardiovascular disease in India   
At the horizon of entry to 21st century the non-communicable diseases especially CAD is 
appearing  as major  threat since CAD has started involving the younger population of India 
with higher severity and diffuse nature of coronary artery disease. Recently CAD in Non 
resident Indians (NRI),[ those who are Indians but live in the European or American 
countries or have migrated to western countries] - have opened a research question for many 
researchers across globe (2). The incidence & prevalence of CAD has been steadily 
increasing especially due to global westernization and on-going urbanization in all parts of 
India. The prevalence of CAD in the urban region (7-10%) is twice as in the rural area (3-
5%).  South Indian residents as compared to North Indians  have higher prevalence of CAD 
(3).The total number CAD patients in India are increasing due to increasing number older 
population {> 60 years } due to increased life expectancy. The risk of CAD in Indians as 
compared to White Americans, Chinese and Japanese is - 3-4 times, 6 times and 20 times 
higher respectively as per study. The prevalence of coronary heart disease has increased  
from 1 %  to 10.5 % within span of around 40 years from 1960 to 1998 in the urban 
population of India with south India being even more higher with prevalence of 11-14.2 % 
(2). Absence of centralized death registries makes it difficult to quote the exact prevalence of 
CAD in India. 
India topped the world with 1,531,534 (~1.5 million) cardiovascular deaths in 2002. Around 
fifty percentage of the CVD –related deaths (52% of CVDs) occur below the age of 50 years 
and one quarter (25%) of CVD deaths occur below the age of 40 years. Incidence of CAD in 
young in Indians is about 12-16% , which is higher than any ethnic group (4) .According to 
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INTERHEART- study,  the age at which the MI occurs first time in South Asian population 
is 53 years, whereas it is 64 years in the Western Europe ,China ,with men are more affected 
than women. The survey included following south Asian countries-India, Bangladesh, 
Pakistan, Nepal, and Sri-Lanka. The CAD/MI in Young – Age less than 40 years occur in  
4.4% of Asian women & 9.7% of Asian men, which is 2 to 5 times higher than European 
population(4). The high burden of CVD is not the only concern in India but also the present 
effect of CVD chiefly on productive age group between 35-65 years. Since CVD manifest at 
an earlier age it can have devastating consequences to both family and society.18 million 
DALY is expected to be lost in working age of 35-64 years due to CAD by 2030 in India 
which is 9 times higher than expected in USA. This pattern would have potential implication 
on India’s growing workforce and economy.(5) 
The INTERHEART study (4) was conducted for establishment of association between all 
risk factors of the world. In South Asians higher proportion of Apo B/ApoA1 ratio and 
smoking were one of chief coronary risk factors for MI as they are usually in all--over the 
world. Despite these risk factors hypertension, central obesity and diabetes had more 
pronounced effects in South Asians. This study has also showed that hypertension and 
diabetes were more causative risk factors in younger Indian female than their male 
counterparts.CAD risk increased incrementally with smoking which also produces higher 
pronounced effects in women than men. Key reasons which have contributed for rapid pace 
of CAD in India are (a)Increased number of older population with increasing overall 
prevalence of CAD and (b) Merging of both type of risk factors of MI in Indians namely 
conventional and non-conventional(6).There are 4 main risk factors for CAD consistent 
across all South Asian – higher Smoking (Current or past), higher ApoB100/ Apo A-I ratio, 
higher hypertension and higher diabetes. Between 1990-2020, the rate of rise of CAD is 
projected to be in the figure of  120% in women,137%  in men in compared to only  30-60% 
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in developed countries.(7). In addition the proportion of STEMI out of all ACS patients  
would be 60% in developing countries in compared  to < 40% by STEMI in developed 
countries (8).This suggest that patient with ACS  in India have much grave  prognosis than 
that of in the developed nations. Also the average age of myocardial infarction at 57 years  in 
India is much lower than that of western countries The patients in India also take longer time 
to reach hospitals and the initiation of treatment is also delayed .Only 8% of the STEMI 
patients undergo primary PCI ,hence the consequent 30 days mortality is higher in Indian 
patients than in the western registries.(9) 
The cardinal features of CAD in India compared to other population in world are: 
1. Higher rates of CAD in India – High prevalence, incidence 
hospitalization and mortality. 
2. Greater prematurity of CAD- 5-10 fold higher rate of MI and death in 
< 40 years and 5-10 years earlier onset of first MI  
3.  Greater severity of CAD-multi-vessel disease common even among 
young premenopausal women, larger MIs with greater myocardial 
damage. 
4. Lower prevalence of hypertension ,obesity, smoking as conventional 
risk factor of MI 
5. Higher prevalence of emerging (thrombogenic) risk factors for CAD-
like high levels of apoprotein B, Lp (a),homocysteine ,triglyceride 
,fibrinogen and small dense LDL & low level of HDL. 
6. Higher proportion of unstable or vulnerable plaque  
Currently in India more than 500 centres are with facility for coronary angiography in 
India however the number is largely disproportionate to the size of CAD burden in 
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country. Extrapolation of Global burden of disease study shows that current burden of 
CAD in India is as high as > 32 million patients with sizeable rural (3-5%) and urban (7-
10 %) population 
In CREATE registry, the proportion of STEMI and NSTEMI was 61% and 39%, the mean 
age of the patients was 57 years, the average time to admission after symptoms was 300 
minutes and mean door to needle time was 50 minutes, the rate of primary PCI in STEMI and 
NSTEMI was very low [only 8% and 7% respectively], STK was used in 59% cases as a 
thrombolytic agent, and the 30 day mortality in STEMI and NSTEMI was 9% and 4% 
respectively. In Global ACS registry, the proportion STEMI and NSTEMI was 30-40% and 
60-70% with mean age of the patients being 64-69 years, the average time to admission after 
symptoms was 140 minutes, the rate of primary PCI in STEMI and NSTEMI was [40% and 
28% respectively], STK was used in 47 % cases as a thrombolytic agent, and the 30 day 
mortality in STEMI and NSTEMI was 8 % and 3 % respectively. In European heart 
survey, the proportion of STEMI, NSTEMI and unstable angina was 42%,51 and 7% 
respectively with mean age of the patients being 63 years, the average time to admission after 
symptoms was 170 minutes and mean door to needle time was 40 minutes, the rate of 
primary PCI in STEMI and NSTEMI was [ 40% and 25% respectively], STK was used in 
37% cases as a thrombolytic agent, and the 30 day mortality in STEMI and NSTEMI was 7% 
and 1% respectively. In US national registry of MI-included only STEMI patients with 
mean age of the patients being 68 years, the average time to admission after symptoms was 
128 minutes and mean door to needle time was 32-38 minutes, the rate of primary PCI in 
STEMI was 32%, STK was used in 21 % cases as a thrombolytic agent, and the 30 day 
mortality in STEMI was 8%.(9)  
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Aims & Objectives of the Study 
Primary Aim: 
To assess the Door to balloon time (DTB) in acute STEMI patients undergoing primary 
percutaneous coronary intervention at Christian Medical College & Hospital, Vellore and to 
assess the factors causing its delay. 
Secondary aims: 
1. To study the clinical and angiographic profile of acute STEMI patients undergoing primary 
PCI at Christian Medical College & Hospital, Vellore. 
2. To assess the in-hospital and 30 days outcome [MACCE] of acute STEMI patients 
undergoing  primary PCI at Christian Medical College & Hospital, Vellore. 
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Review of Literature  
Atherosclerosis is the principle underlying patho-physiologic mechanism of coronary artery 
disease. Atherosclerosis became epidemic as population increasingly survived early mortality 
communicable diseases and malnutrition. The atherosclerosis is slow, progressive and 
proliferative disease which can range from fatty streak formation to frank coronary 
atherosclerotic plaque erosion, rupture & dissection and superimposed thrombus formation. 
However there are multiple non-atherosclerotic causes of coronary artery disease namely 
coronary artery- emboli, dissection, spasm, trauma, arteritis, external compression thrombus 
without atherosclerotic plaque and congenital anomalies. Acute coronary syndromes is a 
result of  unstable coronary artery plaque usually due to plaque erosion or rupture with 
resultant thrombus formation resulting in complete occlusion of coronary artery and or 
arteries which leads to ischemia and hypoxic injury to myocardial cells and tissue. This can 
manifest as unstable angina, NSTEMI, STEMI or as sudden cardiac death (SCD). Sudden 
cardiac death is most commonly due to ischemia induced ventricular tachycardia and 
ventricular fibrillation.  The mortality caused by ACS, STEMI and cardiac arrest have 
reduced drastically  in last 2 decades especially from early recognition of symptoms and 
diagnosis of ACS and effective management . 
The conventional risk factors for CAD are as follows: (1) Hypertension; (2) Diabetes 
mellitus; (3) hypercholesterolemia; (4) Smoking and tobacco use; (5) Physical inactivity; (6) 
old age; (7) Male sex; (8) Obesity .The Non-conventional risk factors and newer 
biomarkers for CAD are as follows: (1) Hyper-insulinemia & Insulin resistance; (2) Lp (a); 
(3) Smaller LDL particle size; (4) Oxidized LDL; (5) Homocysteine; (6) SAA(Serum 
amyloid A); (7) hsCRP; (8)IL-6,IL-18; (9) Myeoloperoxidase; (10) PAI-1 and tPA; (11) 
Fibrinogen; (12 ) sICAM-1; (13) D-dimer; (14) CD-40L 
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The most comprehensive data for trends of cardiovascular diseases in India come from 
CREATE registry, a registry from 89 large hospitals in 10 regions and cities across India for 
ACS .(9)  
1. About 60% patients of ACS patients had STEMI where as in reports from 
developed countries including European heart survey < 40 % had STEMI. This 
suggests patients admitted in India have worse prognosis than those in other countries. 
2. Three – quarters of the ACS patients are from poor & lower middle socioeconomic 
strata that were having low likelihood of routine ACS management. 
3.  The median time from symptom onset to presentation was 300 min in Indian 
STEMI compared to patients in developed countries (range 140-170 min) –Only 
41.6% STEMI patients presented within 4 hours of symptoms and 31 % patients 
presents after 12 hour of symptom onset in India 
4. The median time for patients with unstable angina and NSTEMI was even more in the 
Indian patients (median 420 min) compared to western data for UA/NSTEMI. 
5. Only few people used Ambulance service in India  (call no. 108)  to reach hospitals  
6. The reasons of late arrival to hospitals include financial  cause, lack of awareness of 
symptoms and different types of accessible healthcare systems which prevent direct 
referral to higher centers 
7. The rate of primary PCI for STEMI is lower while fibrinolysis therapy is higher 
than developed countries because more than three-fourth of Indian patients have to 
pay directly for their own treatment. 
8. The equivalent rate of PCI in NSTEMI or unstable angina was 7% in India compared 
to western countries PCI for UA/NSTEMI of 27-37%. 
9. The rate of CABG in India is lower than other registries. 
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10. The Indian STEMI patients have earlier onset of CAD by a decade with higher 30 
day mortality than developed nations which occurs in 9% and 6-8% respectively. 
11. The mortality in NSTEMI is also higher (3.7%)  than that of developed countries 
(range 1-3%) (9). 
 
                                            
            
 
 
 
                                                    
                                                          Non-atherosclerotic plaque5%  
                                                                                                     Spasm                    No spasm 
  
Superimposed thrombus 85%      No superimposed thrombus 15%                  * Figure 1  
Earlier, the presence of minimum two criteria out of three criteria was required for diagnosis 
of myocardial infarction as per WHO and AHA: Characteristic symptoms of ACS, ECG 
changes, and typical rise and fall in biochemical markers.                                                                             
The third version of the Universal Definition of Myocardial Infarction (MI) was published in 
2012. The diagnosis of acute myocardial infarction (AMI) should only be made in a clinical 
setting consistent with acute myocardial ischemia when evidence of myocardial necrosis is 
present. The diagnostic criteria for MI are fulfilled when a 
1. Rise and/or fall of biomarkers (preferentially cardiac troponins) occur with at 
least one value above the 99th percentile of the upper reference limit.  
Luminal narrowing 95%  N or near normal Coronaries 
5% 
Atherosclerotic 95% 
Major Epicardial coronary artery during MI 
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2. In addition, there should be symptoms of ischemia, new ECG changes imaging 
evidence of a new loss of viable myocardium or new RWMA or The 
identification of an intracoronary thrombus by angiography or autopsy.  
This revised definition gives update on previous versions by including changes to diagnostic 
ECG criteria (Q waves to an ECG changes), giving higher emphasis on cardiac imaging, 
modifying the criteria for subtypes of MI and implementing high sensitivity cardiac troponin 
(cTn) assays. The shift to cardiac-specific troponins as the markers of choice for the 
diagnosis of MI requires new cut off values for cardiac injury. The term normal range has 
been replaced by the term upper reference limit, defined as the 99th percentile of a normal 
reference control group. (10) 
The ECG remains key for diagnosis of acute and chronic coronary syndromes. There are 4 
factors which alter findings of ACS on ECG namely :( 1) Duration of ischemic symptoms (2) 
Extent of myocardial damage [transmural Vs sub endocardial](3) Topography (anterior vs. 
infero-postero-lateral or Right ventricular MI )(4) Other underlying abnormalities (LBBB, 
WPW or pacemaker etc.). Under normal condition ST segment is iso-electric because all 
healthy myocardial cells attain action potential at the same time and corresponds to plateau 
phase of cardiac action potential. Ischemia has profound effect on the electrocardiographic 
manifestations and usually manifests earliest and most prominent as deviation of ST segment. 
ST segment elevation ECG is measured: {1} At J point in relation to PR segment {2} 60-
80 ms after J point in relation to TP segment (ST 80 used when Heart rate < 130 per minute 
and ST 60 is used when the Heart rate is > 130 bpm)  
Causes of ST elevation on ECG: Acute ST elevation MI, Takosubo cardiomyopathy, acute 
pulmonary embolism,  myocardiits,  tumour invading myocardium, acute pericarditis, benign 
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early repolarisation LBBB with acute MI (Sgarbosa et al criteria), LVH, LV aneurysm, 
Brugada syndrome, hyperkalemia and Type Ic drugs, Hypothermia, CNS disease 
(Subarachnoid haemorrhage), Prinzmetal angina, Post electrical cardio version   
The diagnosis of STEMI conventionally by ECG requires ST segment elevation of > 1 mm 
in at least 2 contiguous leads except in isolated posterior wall STEMI. In 2013 ACC/AHA 
(11) has changed the following criteria for diagnosis of STEMI or STEMI equivalent as 
per difference in ST segment elevation in different leads, age and sex if the presentation of 
the patient is within 24 hours of the onset of symptoms.  
1. AWMI is considered if  
Lead V2-3 has ST elevation of 2.5 mm or more                              < 40 years male  
                        ST elevation of 2.0 mm or more                               > 40 years male 
                        ST elevation of 1.5 mm or more                               Female of any age 
Or New or presumed new LBBB 
2. ST elevation of 1 mm or more in leads other than V2-3. 
3. Posterior MI  if ST elevation of 1.0 mm or more  in lead V7-9       < 40 years  
                                       ST elevation of 0.5 mm or more in lead V7-9       > 40 years  
Or    new Isolated ST depression of 1 mm or more in at least 2 or more from V1-3 with 
upright T waves  
4. RVMI if ST Ele. of 1.0 mm or more in the right sided leads ( V3R-4R)  < 30 years  
                       If ST Ele. Of 0.5 mm or more in the right sided leads (V3R-4R) > 30 years 
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5. New ST segment elevation of 1 mm or more in aVR with concomitant ST segment 
depression of 0.5 mm at least 2 contiguous leads .(11) 
STEMI distribution: ST segment elevation due to acute myocardial infarction usually 
demonstrate regional or territorial pattern  
AWMI                                     :  ST elevation in V1-6, I, aVL. (ASMI has ST ele V2-V4) 
IWMI                                       :  ST elevation in II, III, aVF. 
RVMI                                      :  ST elevation in V3R-V5R. 
True PWMI                             :  ST elevation in V7-V9 or ST Dep in ant. Leads (V1-3) 
LWMI or Apical MI                 :  ST elevation in I, aVL, V5-V6 
IW+RVMI                                :  ST elevation in II, III, aVF & V3R-V5R  
IW+PWMI                               :  ST elevation in II, III, aVF & V7-V9 
IW+RV+PWMI                        :  ST elevation in II, III, aVF; V3R-V5R & V7-V9 
IW+LWMI                               :  ST elevation in II, III, aVF; I, aVL & V5-V6 
IW+LW+PWMI                       : ST elevation in II, III, aVF; I, aVL & V5-V9 
In presence of LBBB the usual ECG criteria for diagnosis can’t be employed ,hence the 
most used Sgarbosa criteria (12) is used to diagnose acute myocardial infarction in 
presence of ECG evidence of LBBB. 
Criteria                                                                                                    Score  
ST elevation > 1 mm or equal and concordant with QRS                          5         
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ST segment depression in V1-3 > 1 mm or equal                                      3 
ST segment elevation > 5 mm or equal and discordant with QRS            2  
Score 3 or more had a specificity of 98% for acute MI but score < 3 did not rule out MI.(12) 
STEMI management: Both diagnosis and treatment starts with first medical contact 
(FMC). The FMC  is time at which the patient first time is initially evaluated by a 
paramedical staff, physician in the pre-hospital settings or if the patient comes to hospital 
casualty or outpatient clinic after the onset of symptoms suggestive of MI.(13).Any patient 
who has severe retrosternal chest discomfort or pain for more than 20 minutes, first 
differential diagnosis should always be myocardial infarction. Important clues for ischemic 
pain are known case of ischemic heart disease, radiation of chest pain to jaw, either arm or to 
neck, chest pain associated with sweating.  However there are several atypical presentations 
of acute coronary syndrome such as nausea / vomiting, breathlessness, fatigue, palpitation, or 
syncope. Atypical presentation are more likely to be seen  in old age , female sex  and 
diabetic patients which affect the correct management at right time and affect the overall 
prognosis ECG  should taken  as rapid as feasible for timely diagnosis of STEMI  and their 
successful management .  
Reperfusion strategies for STEMI: 
Plaque disruption in the culprit vessel results thrombotic occlusion of infarct-related coronary 
artery during MI.STEMI leads to left ventricular dilatation and ultimately may culminate in 
death of the patient through by a process of combined pump-failure and electrical disturbance 
in the myocardium. Thrombotic occlusion usually persists is most of the patients during 
STEMI while myocardial necrosis is occurring (however late spontaneous reperfusion is also 
noted). Intrinsic fibrinolytic system can cause spontaneous recanlization of occluded infarct-
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related coronary artery in up to one third of the patient beginning at 12-24 hours (Delayed or 
late spontaneous recanalization) (15) (14).The most reliable method of re-establishing the 
flow to ischemic myocardium is timely reperfusion either by thrombolytic agent or by 
performing percutaneous coronary intervention which restore the oxygen demand and supply 
mismatch. The myocardial salvage depend upon whether is treated with fibrinolytics or with 
PCI.  Each 30 minutes delay from symptom onset increases the relative risk of mortality by 
8% (15) 
Figure -2 
Symptom onset                    FMC                Diagnosis                             Reperfusion              
                      Patient delay               ≤ 10 min 
 
                                                                                               System delay 
                                                             Total ischemia time                                                                                 
(16)                                                                                                                            Fibrinolytic                 
                                               Coronary giudewire passes the culprit lesion if primary PCI  
(16) Figure -3  
1. Pharmacologic         ( Thrombolysis and facilitated thrombolysis ) 
2. Invasive strategy      ( Percutaneous coronary  intervention-PCI ) 
3. Pharmaco-invasive strategy  
4. Facilitated PCI 
5. Rescue PCI 
Fibrinolytics / Thrombolysis:  A pharmacologic agent which dissolves the superimposed 
clot or thrombus due to acute plaque rupture or erosion .These fibrinolytic agents converts 
plasminogen to the natural fibrinolytic plasmin. The plasmin lyse the clot by breaking down 
the fibrinogen and fibrin contained in the clot. The first ever used fibrinolytic was  
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streptokinase which was  used employed for lysing the clot in the acute myocardial infarction 
in 1958 by Fletcher and colleagues but the real impetus of opening the occluded coronary 
artery by fibrinolytic was not realized until 1980s when  GISSI trial validated STK as 
effective therapy for acute myocardial infarction(17). This can be employed in either of the 
strategies - In-Hospital thrombolysis or Pre-hospital thrombolysis (usually in the ambulance 
used for transfer of patient if STEMI is confirmed at FMC on ECG by paramedical staff or 
physician. The concept of pre-hospital thrombolysis is based on the fact to reduce the Door 
to needle time (DNT) after diagnosis of STEMI which can be started by skilled ambulance 
staff attending the STEMI patient safely and appropriately especially when journey time to 
hospital is more than 45 minutes.(18)(19) The fibrinolytic can be used as  bolus agents ( t-PA, 
r-PA, TNK) , the earlier other agents are given as infusion. 
 Absolute Contra-indications: any prior ICH, known AVM of brain, known CNS neoplasm, 
ischemic stroke within 3 months except in 3 hours, suspected aortic dissection, bleeding 
diathesis or active bleeding, closed head or facial trauma in last 3 months. 
Relative Contra-indications: Uncontrolled hypertension (History or at presentation), 
ischemic stroke > 3 months, dementia, known CNS pathology not covered in absolute CI, 
prolonged CPR > 10 minutes, major surgery < 3 months, recent internal bleeding within last 
1 month, pregnancy, active peptic ulcer, non-compressive vascular punctures, use of 
Anticoagulants with high INR, prior use of thrombolytic (STK) more than 5 days up to 2 
years.   
Facilitated thrombolysis: the use of additional agent with fibrinolytic to increase its 
beneficial effect. 
The Gp IIb/IIIa inhibitors (abciximab, tirofiban) and antithrombotic (unfractionated heparin, 
low molecular weight heparin and bivalirudin) has been used for this purpose. 
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Pharmaco-invasive therapy: the administration of fibrinolytic therapy either in the pre-
hospital setting or at a non- PCI capable hospital, followed by immediate transfer to a PCI-
capable hospital for early coronary angiography and PCI when appropriate. In the past ten 
years, PCI has replaced thrombolysis as the reperfusion strategy for many patients presenting 
with STEMI. This is the potential therapeutic strategy in those patients in whom 
contemporary primary PCI can’t be employed in evidence based timeframes. This addresses 
the value of routine early PCI after thrombolysis in STEMI patient who are initially 
ineligible for primary PCI .This strategy is especially in those area where PCI capable 
centres are at the distance of more than 120 minutes from villages    {applies to countries 
like India} or in the city where road traffic would hamper the STEMI patient to the reach 
PCI capable centre with this time duration. However, delivery of the primary PCI within 
guideline -based timeframes is challenging and varies substantially worldwide due to various 
constraints .Consequently, even with the ideal circumstances of rapid initial diagnosis, long 
transfer delays to the catheter laboratory can occur. These delays are detrimental to outcomes 
for patients and can be exaggerated by variations in timing of patients' presentation and 
diagnosis. (46) .The various clinical trials have shown the beneficial role of this strategy 
mainly CARESS-in-AMI, TRANSFER-AMI, SIAM III , NORDISTEMI ,CAPITAL 
,GRACIA-1 , WEST and POOLED (17) Facilitated PCI: is defined as a strategy of using 
full or half dose thrombolytic with or without Gp IIb /IIIa inhibitor with immediate transfer 
for planned PCI in 90-120 minutes .This is important to realize that in this strategy the 
decision for performing PCI is already being taken before additional pharmacological 
reperfusion is commenced. Full dose lytic therapy and half dose thrombolytic with 
GpIIb/IIIa inhibitor have been tested for this strategy . With available clinical trials – 
FINESSE (47)  and ASSENT -4 (48) -  this strategy has failed to show the mortality benefit 
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rather  increase in bleeding complications were observed .This strategy  addresses the value 
of pre-treatment with thrombolytic in patients otherwise eligible for primary PCI. Rescue 
PCI or Ischemia guided PCI: PCI done as a rescue procedure in any STEMI patient if the 
thrombolysis has failed .The diagnosis of failed thrombolysis can be made if (a)ST 
resolution at 60 minute is less than equal to 50% (b)After thrombolysis patient experiences 
recurrence of pain or develops acute severe heart failure or cardiogenic shock(c)ECG shows 
re ST-elevation after ST resolution (evidence of re-occlusion after successful fibrinolysis) 
According to REACT (Rescue angioplasty versus repeat thrombolysis or conservative 
therapy) trial has shown beneficial role both at short term as well long term (at or after 1 
year) in terms of event free survival or hazard ratio. (49) 
# Successful thrombolysis refers to disappearance of pain, ST resolution > 50%, and 
occurrence of reperfusion arrhythmia. As with diagnosis of STEMI, ECG can be used as a 
marker for adequate reperfusion after reperfusion therapy either by thrombolytic or after 
angioplasty. These Signs are namely(a) ST segment resolution (STR) > 70% complete , 30-
70% partial, <30 % - No; (b) Early T wave inversion(c) Early appearance of Q waves , 
earlier reappearance of lost S waves and increase in amplitude of R waves in the ischemic 
territory;(d) AIVR (Accelerated idioventricular Rhythm;(e) Bezold Jarisch reflex – sudden 
bradycardia with hypotension after MI (50) 
Primary percutaneous Coronary Intervention {Primary PCI}  
Primary PCI is   defined as an emergency percutaneous catheter intervention 
(angioplasty and or stenting) in the setting of STEMI, without prior fibrinolytic 
therapy. The primary PCI is reperfusion strategy of choice in patients with STEMI, 
provided it is done rapidly within particular time frames laid by ACC/AHA and ESC 
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guidelines. This strategy remains reperfusion therapy of choice whether the patient presents 
to a PCI-capable hospital or not within specified time frames. The experienced team includes 
proficient interventional cardiologist and skilled support staff who are attached with routine 
primary PCI care of STEMI patients. Higher the volume of primary PCI at a centre there has 
been a trend of lower mortality in primary PCI due to increased expertise .The primary PCI 
is gold standard for management of STEMI because of its ability to achieve high 
Perchantage of reperfusion. It is suitable > 90% patients and achieved higher TIMI flow 
grade in 70-90% of the patients. The era of interventional cardiology began in 1978 with 
pilot studies on the feasibility of percutaneous transluminal angioplasty (PTCA).The use of 
angioplasty as main method of opening a occluded vessel was earlier termed primary 
angioplasty but in the current era of coronary stents and other devices it is referred as 
primary percutaneous coronary intervention. 
Invasive strategy with primary PCI is preferred reperfusion technique because 
1. Nearly eliminates the risk of ICH  
2. It is the reperfusion therapy of choice in acute MI few of these conditions like 
cardiogenic shock, severe heart failure, electrical instability or hemodynamic 
instability. 
3. Up to 10 % of patients presenting with STEMI may require CABG based on multi-
vessel disease or left main stenosis and these patients can be identified sooner with 
invasive approach.  
4. PCI patient have lower rates of repeat MI, CVA - stroke and short term overall death 
than thrombolytic therapy  in a meta-analysis of 23 randomized control trials.(20)(21)
Landmark trial PAMI (Primary angioplasty in acute MI) compared the treatment of 
STEMI by thrombolysis (t-PA) or primary angioplasty and result clearly was in favour of 
primary angioplasty group {In hospital-mortality was 2.6% vs. 6%} and combined endpoints 
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of death and non-fatal infarction was 10% vs. 26%. The benefit of PAMI persisted even at 
long term of 2 years also. Multivariate analysis found PAMI to be independently predictive 
of reduction in death, re-infarction or target revascularization(21)  
Clinical evaluation and hemodynamic assessment: For the patient who presents with 
criteria for Primary PCI, a targeted history with physical examination should be performed. 
The relevant symptoms with risk factors, history of allergies, bleeding risk, current use of 
anticoagulant therapy history of renal disease and functional class. This also involves the 
monitoring heart rate and rhythm, arterial blood pressure, repeated auscultation of chest for 
pulmonary congestion, urine flow and examination of skin and mucus membrane for 
adequacy of systemic perfusion. 
Table 1 Hemodynamic classification of patients with AMI (Killip - Kimball & modified by 
Forrester ,Diamond, Chatterjee) (22)(23)(24) 
 
Based on Clinical examination  Based on Invasive monitoring  
Class Definition Class Definition  
PCWP in mm Hg , CI in 
l/min/m2  
I Rales and S3 absent  I Normal hemodynamics PCWP 
< 18, CI> 2.2  
II Crackles , S3 and raised JVP 
present 
II Pulmonary Congestion  
PCWP>18 , CI> 2.2  
III Frank pulmonary edema III Peripheral hypo perfusion 
PCWP <18, CI<2.2 
IV Shock IV Peripheral hypo perfusion and 
pulmonary congestion  
PCWP >18, CI< 2.2  
 
The Killip’s class were initially given for the patients of AMI managed conservatively in 
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coronary care units but  the pooled analysis of ~2500 patients from three primary angioplasty 
trials have shown the utility of this simple and useful independent predictor of mortality in 
primary PCI as well.(25) 
 
The death  of STEMI patient during its management is determined by : age of the patient , 
Killip’s class at time of initial assessment, delay in treatment, type of treatment strategy, 
history of old myocardial infarction, presence or absence of  diabetes mellitus, renal failure, 
extent of  CAD (no. of coronary arteries diseased) , LV ejection fraction..There are various 
scoring systems for risk assessment of STEMI at the presentation which includes TIMI risk 
score for STEMI (26), PAMI score, Zwolle risk score and GRACE score. All scores 
performed equally when used to predict mortality independently in patients undergoing 
primary PCI during in current practise.(27) 
The TIMI risk score showed increment trend of mortality with increasing sum of risk score.{ 
0 risk score had mortality of 0.8% and the score of > 8 had mortality of ~ 36% } .The TIMI 
risk score was developed in Cohort of fibrinolytic treated STEMI patients but it has also 
been validated as tool to predict the mortality even in patients undergoing primary PCI (28) 
 
Table-2 - TIMI risk score for STEMI (26) 
Variables  Points 
 Age 65-74 Years                                            2 
Age 75 or more Years                                     3 
SBP <100 mmHg                                            3 
Killip’s Class II-IV                                          2 
Heart Rate>100/min                                        2 
Anterior STEMI or LBBB                              1 
Diabetes/Hypertension or history of Angina   1 
Weight < 67 Kg                                               1 
Time to treatment > 4 hours                            1 
  
                                                                                                           Total Points 0-14 
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Primary PCI achieves and maintains the coronary artery patency and avoids bleeding 
risk of fibrinolytics especially the serious or major bleeding like intra-cerebral 
haemorrhage. Various RCTs  have shown the pre-eminence or superiority over in-hospital 
thrombolysis.(29) 
Oral Antiplatelet therapy :  
162-325 mg of Aspirin should be given before primary PCI  Class I (LOE-B) and thereafter 
should be continued indefinitely  Class I (LOE-A) 
A loading dose of theinopyridine drug (either Clopidogrel 600 mg or Prasugrel 60 mg or 
Ticagrelor 180 mg ) should be given as early as possible that should be followed by 
maintenance therapy for at least one year 
 (Clopidogrel 75 mg or Prasugrel 10 mg  daily or Ticagrelor 90 mg twice daily) Class I 
(LOE-B) 
Antithrombotic treatment : 
A bolus dose of UFH 100 IU /Kg is recommended (60 IU/Kg if Gp IIb/IIIa inhibitor is 
used)and subsequently to maintain ACT of 200-250 sec) 
Bivalirudin as an alternative anticoagulant has been approved for primary PCI with bolus 
doe of 0.75 mg / Kg IV followed by 1.75 mg / Kg per hour. HORIZONS-AMI trial showed 
the reduction in mainly bleeding rates as compared to UFH and there was decreased in 
mortality at 30 days as intention to treat analysis but there was increase in rates of stent 
thrombosis. 
At present due to lack of evidence the LMWH and Fondaparinux use during Primary PCI is 
not recommended. 
Platelet Glycoprotein IIb/IIIa inhibitors: The role of Gp IIb/IIIa inhibitor in primary 
PCI,of which abciximab has been extensively studied and has been evaluated in major 
randomized trials (CADILLAC,BRAVE-3,HORIZONS-AMI).The meta-analysis for use of 
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abciximab have shown that it was associated with reduction of mortality and re-infarction 
rates(30).Tirofiban as Gp IIb/IIIA inhibitor was studied in On-TIME 2 trial and showed 
significant benefit in greater ST resolution and benefit in combined endpoints of death, 
recurrent MI, and urgent target vessel revascularization. 
Stenting is preferred over balloon angioplasty alone because balloon angioplasty can be 
associated with restenosis in 50 % patients undergoing primary PCI by angioplasty alone 
which requires target vessel revascularization in as high as 20% of the patients. Which 
suggest to recommend that routine stent implantation after PTCA which can improve late 
procedural outcomes as suggested by PAMI trial and meta analysis of several other trials 
(31)(32). 
BMS or DES : Meta analysis (of eight RCTs namely TYPHOON, STRATEGY, SESAMI, 
BASKET AMI, MISSION, PASSION etc.) were undertaken for assessing the superiority 
of bare-metal stents {BMS}  or drug eluting stents {DES} during primary PCI which 
revealed that target lesion revascularization is less with DES as compared to BMS (33) but 
there is similar number of stent thrombosis and repeat MI or death in either types of stents 
but there is increased late stent thrombosis in DES group .(34) .HORIZONS-AMI trial has 
also shown these results that DES is superior in reduction in TLR and TVR.  
According to current evidence, PCI of the  infarct related artery during primary PCI is 
only recommended  instead of full revascularization during acute MI situation unless there 
is presence of cardiogenic shock and persistent ischemia after PCI of supposed infarct-
related culprit lesion (35)(36). 
Radial or femoral access: The primary PCI can be employed using radial artery access 
which is preferred over the conventional femoral artery access chiefly because the bleeding 
and hematoma complication are higher with femoral approach as has been seen with RIVAL 
and RIFLE STEACS trials (better cardiac mortality and morbidity with radial access over 
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femoral)(37)(38). 
Thrombus aspiration by the use of thrombectomy catheter {e.g. Export catheter or Pronto 
etc.) - micro vascular injury which is chief cause of no reflow or slow flow phenomena after 
PCI. No -reflow or slow-flow phenomena  is defined as inability to adequately perfuse the 
myocardium after temporary occlusion of an epicardial coronary artery without any evidence 
of mechanical obstruction(42).The process starts during ischemia increases with reperfusion 
and can be exacerbated by athero-embolization. There are many mechanism of micro 
vascular injury – (a) distal micro and macro embolization due to ballooning or stenting, (b) 
oxygen free radicals, (c) calcium overload, (d)endothelial dysfunction, (e)cellular and 
interstitial edema , (f)endothelial dysfunction, (g) inflammation and (h)vasoconstriction. The 
sub endocardial region is chiefly affected and despite achieving TIMI 3 flow the myocardial 
perfusion is still impaired. The reported incidence during primary PCI is 11.5 % which is 
higher than that occurs during elective PCI. The diagnosis of no-reflow can be made with 
ECG, myocardial contrast echo, Cardiac MRI with Gadolinium and Colour Doppler 
imaging. Routine use of thrombus aspiration catheter can prevent this and treatment involves 
use of intracoronary NTG, verapamil, nicorandil, adenosine and or abciximab even use of 
over the wire balloon and distal contrast injection to mechanically dislodge the micro-
thrombus. Slow flow or No re flow has been correlated with poor outcome after primary PCI 
after establishment of coronary flow. Thrombus aspiration by thrombectomy device prevent 
the migration and distal embolization of thrombus and prevent micro vascular injury and 
hence improves post PCI TIMI flow , myocardial blush grade and ST resolution .The benefit 
is mainly derived by TAPAS and DEAR-MI, and REMEDIA trials ,however result of 
INFUSE-AMI and TASTE trial differ from the earlier trials and have not shown mortality 
benefit at one month after primary PCI .However according to recent guideline of 
ACC/AHA ESC ,routine thrombectomy is  still considered Class IIa during primary 
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PCI.(16)(39)  
Routine use of embolic protection devices (namely- Guardwire , triactive system or Filter 
wire ) is not recommended during primary PCI as suggested by DEDICATION trial  
(26).Routine use of IABP is limited because of associated increase in bleeding 
complications as suggested by meta-analysis of several clinical trials .The routine use of 
IABP in STEMI patients in absence of  cardiogenic shock did not decrease mortality, re-
infarction or rate of recurrent angina but in the presence of cardiogenic shock the use of 
IABP showed significant reduction in the mortality { Class I LOE C }.In both the groups 
whether or not associated with cardiogenic shock the use of IABP increased moderate to 
severe bleeding . (40) 
Suboptimal perfusion after primary PCI: The main aim of STEMI treatment is to achieve 
normal myocardial reperfusion in the territory of infarct related artery. One of the most 
widely used measures of reperfusion  therapy is TIMI angiographic flow grading(41).Most 
of the causes of failure to achieve TIMI 3 flow are as a result of persistent pathological 
process (persistent stenosis or thrombus and coronary vaso-spasm) or mechanical 
complications during primary PCI (coronary artery dissection , acute stent thrombosis, 
branch occlusion,  failed stent deployment , distal macro –or micro-embolization. 
Table-3- TIMI flow grading (41) 
Grade 0  Complete occlusion of the infarct related artery  
Grade 1 Some penetration of contrast beyond obstruction but without the 
perfusion of distal coronary bed  
Grade 2 Perfusion of the entire infarct vessel into the distal bed with delayed flow 
compared to normal artery  
Grade 3 Full perfusion of the infarct related vessel with normal flow 
 
There are several complications of myocardial infarction which can be absolutely benign to 
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the complications which require immediate attention.  These complications are LV 
dysfunction,  pump failure , cardiogenic  shock, mechanical complications { due to free wall 
rupture, acute MR by papillary muscle  rupture, ventricular septal rupture, true and pseudo-
aneurysm}, RV infarction , arrhythmias {both tachy and bradyarrhythmias which includes 
ventricular premature complexes to ventricular tachycardia to atrio-ventricular blocks to 
asystole to supra-ventricular arrhythmias },recurrent chest discomfort and recurrent 
infarction , pericarditis  and pericardial effusion , LV thrombus and arterial embolic  
phenomena 
During acute MI the indications requiring temporary pacemaker insertion are development 
of new bilateral bundle branch block {RBBB+LAHB or LPHB or alternating BBB}, CHB or 
trifascicular block. 
Most of the patients with myocardial infarction patients those who don’t  have significant 
ventricular arrhythmias, recurrent ischemia, or congestive heart failure can be discharged 
safely within 5 days of MI. Pre-discharge LV ejection fraction of the patient remains 
important tool for predicting risk stratification. The reduced ejection fraction post MI can be 
related to irreversible damage to myocardium or reversible myocardial injury. The reversible 
injury usually caused by myocardial stunning or hibernation. Exercise or pharmacologic 
stress Echocardiography, stress radio nuclear imaging (PET) or stress Cardiac MRI can 
differentiate these conditions and indicate the use of reperfusion therapy after MI.  
Few complications like No-reflow[ already described with thrombus aspiration] , Stent 
thrombosis, related to PCI – reperfusion therapy requires special mention 
Stent thrombosis : According to Academic Research Consortium (ARC), ST can be defined 
as   (43) Based on timing Stent thrombosis can be  divided into 
1) Acute ST           { within 24 hours of stent deployment } 
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2) Sub-acute ST   { between 1 day to 30 days } 
3) Late ST            { between 30 days to 1 year} 
4) Very Late ST   { after 1 year }  
Based on evidence of Stent Thrombosis can be divided into  
1) Definite ST : Presence of thrombotic occlusion that originates in the stent or in 5 
mm nearby the stented  segment with one of the following criteria for MI like  
ischemic chest pain, ECG changes, or typical rise and fall in cardiac biomarkers or 
with pathologic confirmation of ST (presence of thrombus at autopsy or via 
examination of tissue retrieved after thrombectomy. 
2) Probable  ST: any unexplained death within 30 days of stent deployment or in the 
presence of any MI related to acute ischemia in the territory of implanted stent 
without necessarily angiographic confirmation of ST 
3) Possible ST: any unexplained death from 30 days after PCI until the end of the 
follow up.  
 
TIMI major bleeding: is defined as drop in Hemoglobin > 5 gm%, occurrence of ICH, 
drop in heamatocrit > 15%. 
Minimizing delay during management of acute STEMI is vital from 2 important reasons:                                 
(a) very early phase of MI is the crucial period where patient experiences pain and during this 
time there is maximum likelihood of occurring primary ventricular fibrillation                                                  
(b) the maximum benefit of STEMI treatment occurs during the early phase only.  
Pain to door time (PTD) or commonly referred as window period (W.P.) is the time 
interval between symptom onset (most likely acute severe chest pain) to the arrival of patient 
to hospital or first medical contact. 
Door to balloon time (DTB)  is the time interval between patient arrival to hospital or 
contact with medical faculty  to inflation of first balloon  { the earliest time recorded for a 
wire or other alternative device reaching culprit  lesion} .It is measured currently as time 
between first medical contact (arrival at the hospital door)  to wire passage into the culprit 
coronary artery (16). Alternatively now-a-days it is also known as FMC to Device time.   
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There has been a debate for time frames which are used for calculation of the Door to balloon 
time (DTB) .Several studies have utilized different ways to calculate DTB. A study was 
conducted to know the different  ways to calculate door to balloon time from more than 1400 
hospitals of USA during primary PCI  and was published in 2007 in JACC .DTB time 
according to Hospital Quality alliance (HQA)  was assessed as the time from hospital arrival 
to angioplasty balloon inflation in patients with STEMI .When use of an angioplasty balloon 
was not documented, the earliest time recorded for a wire or other alternative device reaching 
a lesion was used instead whereas according to national cardiovascular data registry (NCDR) 
DTB was assessed using slightly different criteria and measured as “ time from hospital 
arrival to first attempt at reperfusion.(51) 
Since mere crossing the culprit lesion by coronary guide wire in patients with acute ST-
segment elevation myocardial infarction (STEMI) does establish the reperfusion in the distal 
coronary bed or achieve TIMI III flow it may still have weak association with outcome  of 
the reperfusion strategy .To address this issue a study was conducted to assess the accuracy of 
using door to balloon time as predictor of outcome in primary PCI .The results showed that 
conventional door to balloon time was unavailable for 23% patients due to various reasons 
like : spontaneous TIMI 3 flow reperfusion without indication for immediate PCI , contra-
indication for PCI (distal occlusion, culprit vessel diameter less than 2mm), and failure in 
occlusion crossing by the guide-wire. It was suggested to use the Door to Reperfusion time 
/ Door to TIMI III flow time rather than using just door to balloon time. { Except in those 
patients in whom TIMI III could not achieved due to no-reflow or slow flow phenomena } 
.The door to reperfusion or TIMI III flow was possible to calculate in > 95 % of these 
patients, so it can be concluded that using Door to TIMI III is more reproducible and better 
predictor for outcome in STEMI patients undergoing primary PCI.(52) 
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The relationship between symptom onset to balloon time and door to balloon time to 
mortality was looked in 2nd NRMI which was conducted between 1994 to 1998 and results 
were published in JAMA in 2000 ,has shown that median door to balloon time was 1 hour 56 
minutes and the adjusted mortality risk was 41 to 62 % higher respectively if the door to 
balloon time was between 121-150 minutes and 151-180 minutes respectively.(53) 
The effect of Door to Balloon time to mortality is observed from largest NRMI registry 
analysis (n= 29,222) in 395 hospitals in USA was published in 2006, longer the DTB  were 
associated with higher mortality (3%, 4.2%, 5.7%, 7.4% for DTB of ≤90 min, 91-120 min, 
121-150 min and > 150 min respectively).(54) 
 
The “Time is myocardium” is famous adage in cardiovascular medicine .Pooled analysis of 
twenty five randomized clinical trials done by Boersma et al comparing the delay for 
revascularization by primary PCI and thrombolysis have clearly shown that primary PCI was 
superior than thrombolysis but maximum benefit was achieved when the treatment delay was 
less than 35 minutes after which the impact of treatment was negated.(55) According to 
Boersma  et al (55),% mortality in thrombolysis group vs. primary PCI based on presentation 
delay- if it was 0-1 hours was- the mortality rate was  6 and 4.7% respectively, if 1-2 hours-
6.2% and 4.2%, if 2-3 hours-7.3% and 5.1%, if 3-6 hours-9.5% and 5.6%, if > 6 hours-12.7% 
and 8.5% with overall rate of mortality being 7.9% and 5.7%.Similarly mortality according to 
treatment delay by Boersma et al  (55) was 8.2% and 2.8% in thrombolysis and primary PCI 
group if treatment delay was 0-35 minutes, if it was 36-50 minutes the mortality rate was 
6.8% and 5.4%, if 51-62 minutes-there was 5.4% and 4.85 mortality, if it was 63-79 minutes- 
the death rate was 9.55 and 6.95, if it was 80-120 minutes the mortality rate was 9.6% and 
6.6% and overall 7.9% and 5.3%. 
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Door-to-balloon time can now be used as a performance index and is the focus of regional 
and national quality-improvement measure. According to Cath PCI Registry , the annual 
trends in door-to-balloon times and in-hospital mortality using data from 96,738 admissions 
for patients undergoing primary PCI for STEMI  from July 2005 through June 2009 at 515 
hospital were analysed and has shown that despite showing decline in door to balloon time 
annually from 83 minutes { between July 2005 to June 2006 } to 67 minutes { between July 
2008 to   2008-2009] .The registry also have shown that number of patients increased from ~ 
60% to 83% in whom primary PCI was performed  with door to balloon time  90 minutes or 
less. The conclusion which was drawn was that that additional strategies are needed to reduce 
in-hospital mortality in these population because  despite national door-to-balloon times 
improvement significantly for patients undergoing primary PCI for STEMI , in-hospital 
mortality has remained virtually unchanged(56).The role of door to activation time on final 
door to balloon time was assessed from registry of 347 consecutive patients diagnosed with 
STEMI from 2 primary PCI centres in 30 months duration. The result revealed that door to 
activation time < 20 minutes would have chance to achieve  to door to balloon time of < 90 
minutes in 83 % time rather than if door to activation time of > 20 minutes  where chances of 
achieving door to balloon time was only 28% . It can be concluded that Door to activation 
time of < 20 minutes is key to achieve door to balloon time of < 90 minutes. (57) 
PCI-related delay’ is the theoretical difference between the time of first medical contact 
(FMC)  to balloon inflation or such device or passage of wire across culprit  minus the time 
from FMC to start of fibrinolytic therapy (i.e. ‘door-to-balloon’ minus ‘door-to-needle’). 
Delay in reperfusion in STEMI during Primary PCI:  
Patient delay: that is - the delay between symptoms onset to first medical contact (FMC). 
Public awareness should be created to minimize this delay by recognizing the symptoms 
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earlier, utilizing the emergency medical services (including Ambulances 108) and by 
education of CAD patient and their families regarding the common symptoms of acute 
coronary syndrome and practical steps to be taken if situation arises.  
Delay between FMC and diagnosis: is the time taken to record the first ECG .It  is a index 
of quality of care The hospitals and emergency medical services participating in the STEMI 
management the goal for this  should be to 10 min or less. 
Causes of Patient related delay (reflects delay in Pain to Door time)  
 Public unawareness of common symptoms of STEMI  
 Atypical presentation of STEMI 
 Negligence of mild symptoms  
 Unawareness of utilizing EMS services ( Ambulance - call no. 108 ) 
 Transport delay to reach to PCI capable centre 
Delay between FMC and reperfusion therapy:  - time taken from FMC to wire passage 
into the culprit artery. This is the ‘system delay’  
The FMC to reperfusion goal should be delay of ≤90 min. 
In high-risk cases with large anterior wall infarction and those patients who present early 
within 2 h, it should be ≤60 min. 
In PCI-capable hospitals, the goal should be to achieve a ‘door-to-balloon’ delay ≤60 min. 
From the patient’s perspective, the delay between symptom onset and provision of 
reperfusion therapy is the most important, since it reflects total ischemia time (which 
includes both window period and door to balloon time). It should be reduced as much as 
possible (58) (59). 
 
The maximum benefit of reperfusion therapy is in the first 2-3 hours for mortality reduction 
after onset of the symptoms of MI. This benefit is achieved by myocardial salvage. The 
earlier the reperfusion better is the outcome “Earlier the better” (18)  
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Causes of System delay (reflects delay in Door to balloon time) 
 Delay in ECG 
 Delay in diagnosis and evaluation of the patient  
 Delay in decision for reperfusion therapy by patient and relative(s) due to 
finance related delay  
 Delay in activation of Cath lab team  
 Delay in preparation of patient for primary PCI (Early Standard STEMI care 
premedication ,wrist and groin shaving ) 
 Consent related delay (Delay in Consent for primary PCI ) 
 Hemodynamic instability (Hypotension /Severe heart failure /cardiogenic 
shock/Pulmonary edema requiring ventilator or inotropic support or arrhythmia 
either  bradyarrhythmia / tachyarrhythmia ( VT/VF) requiring emergency TPI or 
requiring defibrillation therapy )  
 In Hospital transportation delay  
 Cath lab busy  
 Difficult Vascular access  
 Difficulty in crossing the coronary lesion (Large thrombus / Difficult Coronary 
anatomy , multi vessel disease etc  ) 
A systemic review of factors predicting Door to balloon time was done after inclusion of 90 
papers searched from NLM Gateway and Cochrane CENTRAL and was analyzed. The 
factors which predicted longer door to balloon time were: pre-hospital delay in presentation, 
cerebrovascular disease, absence of chest pain, lower PCI volume and specialization hospital, 
lower sum ST elevation, absence of Q waves and left bundle branch block. The factors which 
predicted shorter door to balloon times were associated with: presentation during regular 
hours, PCI in a more recent year, 24 hour on site cardiology, pre-hospital ECG, single call to 
central page to activate the catheterization lab, ER physician activating the Cath lab, lab staff 
arriving within 20 min of paging and culprit vessel PCI before full diagnostic 
angiography.(60) 
 
 33 
 
Pa
ge3
3	
Despite adequate measures, the door to balloon time of < 90 minutes is achieved in a small 
percentage of patients, the reasons being many. There is only one Indian study which has 
been done in Indian STEMI patients undergoing primary PCI which has assessed the factors 
that cause delay in Door to balloon. (61)  
In stable patient with persistent occlusion of infarct-related artery  detected beyond 3 days up 
to 28 days after acute MI.  , the routine PCI compared to medical management in the large 
Occluded Artery trial (OAT) revealed no clinical benefit. (62)(63) 
According to latest guideline led by ACC/AHA for management of STEMI in 2013 
(39)Class I  
1. All communities should create and maintain a regional system for STEMI 
management that includes assessment and continuous quality improvement of 
emergency medical services .Performance can be facilitated by participating in 
programmes such as mission: Lifeline and Door to balloon alliance (LOE :B) 
2. Performance of 12 lead ECG at the site of first medical contact is recommended (LOE 
:B) 
3. Reperfusion therapy should be administered to all eligible STEMI patients with 
symptoms of less than 12 hours. (LOE :A) 
4. Primary PCI is recommended method of reperfusion when it can be done in timely 
fashion by experienced operators * (LOE :A) 
5. Emergency medical services should transport the patient of STEMI directly to PCI 
capable centre if FMC to device time goal is less than 90 minutes. (LOE :B) 
6. Immediate transfer to PCI capable centre is preferred triage strategy if FMC to device 
time goal is less than 120 minutes. (LOE :B) 
7. In absence of contraindication of thrombolytic, fibrinolytic therapy should be 
administered to patients with STEMI if patient present to PCI non-capable centre and 
FMC to device time exceeds 120 minute. (LOE :B) 
8. If fibrinolytics are administered, the FMC to needle time should be less than 30 
minutes. (LOE :B) 
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Class IIa: Reperfusion therapy is reasonable for the STEMI patients who presents in 12-24 
hours of symptoms onset and who have clinical and or ECG evidence of ongoing ischemia 
Primary PCI is the preferred therapy of choice in these patients. (LOE: B)  
*Operator experience >75 PCI per year, with PCI centre > 200 PCI per year of which at 
least 36 primary PCI per year. 
Table –4- ESC Guideline for STEMI management aspects of primary PCI (16) 
 
Recommendation COR LOE
Indication of Primary PCI 
Primary PCI is  reperfusion therapy of choice if performed by experienced 
team within 120 min of FMC 
I A 
Primary PCI is indicated in acute MI with  severe heart failure and cardiogenic 
shock unless the expected PCI delay is excessive and patient present early after 
symptoms 
I B 
Procedural aspects of Primary PCI 
Stenting is preferred over balloon angioplasty alone I A 
Primary PCI should be limited to culprit vessel unless causing cardiogenic 
shock or persistent ischemia after PCI of suspected culprit lesion 
IIa B 
Radial access preferred over femoral access (if performed by experienced 
operator) 
IIa B 
If no Contraindication of DAPT and patient  is likely to compliant , DES is 
preferred over BMS 
IIa A 
Routine thrombus aspiration is considered  IIa B 
Routine use of distal protection device and use of IABP not recommended  III C,A 
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Material and Methods 
Setting:  
This study was conducted at Cardiology department of Christian Medical College; Vellore 
(T.N.).This is a single tertiary care centre prospective observational study. 
 A total of 96 STEMI patients were recruited during study period - Dec 2012 to Nov. 2013. 
Christian Medical College Hospital (CMCH), Vellore is one of the largest tertiary care 
medical referral centres of India encompassing patients from almost every state of India and 
as well as patients from other countries of world, which is enriched with > 2300 bed capacity. 
Cardiology department of Christian Medical College Hospital is one of the oldest tertiary 
care cardiac centres in India which is equipped with 24 × 7 availability of PCI capable team 
and cardiac surgery back-up. Cardiology department of CMCH, Vellore caters > 4250 cardiac 
admissions ,~ 70,000 cardiac patients being seen cardiology OPD annually, treats around 
700-800 STEMI per year and around 750 total number PCI are done per year out of which 
around 200 are primary PCI. The hospital has three state of the art cardiac catheterization 
labs. Cardiology department owns all modern high technology Cath lab machines, Echo & 
ECG machines, Holter monitors, TMT machines and electrophysiology lab and is well 
supported from radiology by all types CT, Cardiac MRI, Nuclear imaging including SPECT 
& PET .Almost all possible biochemical investigation is available at the CMCH, Vellore, 
which attracts large clientage of patients to it of all types from poor to rich. 
Inclusion Criteria:  
All patients presenting with acute STEMI were offered Primary PCI. Patients who chose 
primary PCI as a mode of reperfusion were included in the study. 
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All patients of Acute STEMI who underwent Primary PCI at Christian Medical College, 
Vellore during the study period. 
Exclusion Criteria:  
1. Patient who refused to give informed consent. 
2. Age < 18 years  
3. Pregnant female with STEMI  
Duration of Study: 12 months {During Dec 2012 to Nov 2013}  
Variables &Data collection: 
The prospective information on variables including age, gender, and history of diabetes 
(defined as fasting glucose > 126 mg/dl, HbA1c > 6.4 or on treatment), hypertension (systolic 
blood pressure > 140/90 mmHg or on treatment), dyslipidaemia (fasting total cholesterol > 
200 mg/dl, LDL > 100 mg/dl, HDL in males > 40 mg/dl or in females < 50 mg/dl, TG> 150 
mg/dl or on treatment), Smoking (either current or past history), prior to history of CAD, PCI 
or coronary artery bypass grafting (CABG),family history of IHD, presence of CKD / PAD 
and stroke, were included for demographic characteristics. 
 Killip, s class {on admission} was documented, presence of cardiogenic shock anytime 
during index hospitalization (defined as systolic blood pressure [SBP] of < 90 mmHg for at 
least 30 minutes, or requirement of inotrops to maintain a SBP >90 mmHg), need of 
intubation and/or Intra aortic balloon pump (IABP) 
Door to balloon time (DTB) is the time interval from patients’ arrival at the hospital to 
coronary guide wire passing through culprit coronary artery lesion. We also documented their 
Pain to door time [PTD] or Window Period-is the time interval between symptom onset to 
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the arrival of patient to our hospital and total ischemia time (which includes both PTD and 
DTB). 
These STEMI patients were admitted directly in cardiac emergency {Chest Pain Unit – CPU 
group} or General emergency {Casualty group}. The calculation of DTB was done separately 
for the patients presenting to either CPU or Casualty. 
CPU {Chest Pain Unit }- a preferred Door for myocardial infarction Patients - CMCH, 
Vellore is one of the  largest medical college with  hospital in India having a separate cardiac 
emergency dedicatedly dealing with all cardiac emergencies like Acute MI 
(STEMI/NSTEMI) ,Heart failure ,arrhythmia etc .CPU is having 24X7 available cardiology 
duty doctor with CPU nursing staff who deal with acute MI patients throughout the day & 
night .The presence of CPU in CMCH, Vellore cut shorts the delay of STEMI patients  in 
initially presenting to casualty then rerouted to cardiology department.  
Casualty or A&E {Accident & emergency department} – a alternative Door for 
myocardial infarction patients – CMCH, Vellore also has casualty which deals with all the 
patients of  the medical (including STEMI/NSTEMI heart failure, arrhythmia), surgical and 
trauma emergency. Unfortunately STEMI patients who are unaware of CPU at CMCH may 
also present initially to casualty for chest pain. In casualty these patients are triaged based on 
priority by duty nurse and then seen by duty doctor (CMO-casualty medical officer). If 
Patient is found to have symptoms & or ECG suggestive of STEMI, immediate cardiology on 
call duty doctor is informed by CMO .Cardiology registrar immediately attends the patient in 
casualty, re-evaluates and offers the reperfusion Primary PCI to all patients and shifts the 
patient to cardiology department (CPU/CCU) for immediate reperfusion therapy 
simultaneously activating the STEMI care team. Despite an efficient system in rapidly 
triaging all patients in casualty there may be sicker patients of trauma or other medical or 
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surgical / trauma emergency or patient in cardio respiratory arrest (medical or surgical 
patient) who might get priority over chest pain patient (more chances of delay if milder 
symptoms or atypical presentation of STEMI), which causes delay in early diagnosis and 
information to cardiology department about the new acute STEMI patient for reperfusion 
therapy. 
As the primary aim of the study was to calculate the door to balloon time and to determine 
the causes of delay for DTB > 90 minutes, the time intervals were divided into 7 
interdependent variables and added to determine total DTB. The casualty delay was also 
added if patient initially presented to casualty instead to CPU. 
We incorporated the digital clocks in all working areas (CPU, CCU, Cath lab) and we 
synchronized all clocks with defibrillators, Cath-lab systems which gave us the 
uniformity for timing after pilot study for calculate DTB. 
(1) ECG time : time interval from hospital arrival to first ECG with ST elevation in patients 
with symptoms suggestive of MI 
(2) Diagnosis and evaluation time : time from ECG to evaluation and diagnosis of STEMI 
(3) Patient decision and finance arrangement time:  diagnosis to finance arrangement time  
(4) Preparation time : time from finance arrangement to preparation for primary PCI 
(5) Transport time: preparation to intra-hospital transport time till entry to Cath-lab. 
(6) Vascular access time: after Cath-lab entry till vascular access time  
(7) Wiring time : vascular access to coronary guide wire passage through culprit lesion 
(8) Casualty delay : delay in door to balloon time,  if patient presents to casualty, rather than 
at CPU 
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 # Usually in the casualty, this is observed that there is delay in doing ECG than that of CPU, 
delay in initial assessment done by CMO {busy in other sick patients or lack of expertise in 
cardiac emergencies}, delay in information to cardiology department, time taken in attending 
the patient in casualty by cardiology doctor, time taken for transfer from casualty to 
cardiology department –CPU/CCU after being assessed by cardiology doctor. 
§ Cath-lab activation at our centre is done by cardiology doctor rather by CMO 
We also compared the DTB to time of PCI and day of PCI, with mode of payment. 
Primary PCI Procedure: 
Primary PCI was performed in standard fashion using a variety of guiding catheters, coronary 
wires, balloons and stents. The majority of interventions were performed via the radial route. 
However, the choice of route was on discretion of operators and few numbers of 
interventions were performed via femoral route {especially with hemodynamically unstable 
patients}. All patients received Aspirin 300 mg, clopidogrel 600 mg (loading dose), 5000-
7500 IU unfractionated heparin and Platelet glycoproteinIIb/IIIa inhibitor {tirofiban in our 
study}. Thrombus aspiration catheter, intracoronary Nitro glycerine, and adenosine use were 
at the discretion of operators). Angiographic and procedural details (culprit vessel, number of 
diseased vessels, use of stents, GP IIb/IIIa inhibitors, TIMI flow was analysed prior to PCI 
and after PCI. All patients were prescribed Aspirin 150 mg, Clopidogrel 150 mg and 
Atorvastatin 20-40mg daily at the time of discharge from the hospital. Patients were followed 
in OPD at 30th day. Those who did not come to the OPD, they were contacted via telephone 
and follow up was documented. Patients were followed at 30 days of procedure for 
recurrence of angina, dyspnoea, any event like recurrence of MI or stent thrombosis or death. 
The MACCE (major adverse cardiovascular and cerebrovascular event) rate in-hospital and 
at 30 days was measured - death rate both in-hospital and at 30 days follow up, TIMI major  
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bleeding, recurrence of CHF or recurrence of MI fatal or nonfatal, stent thrombosis or stroke 
was analyzed. 
Sample Size: ࢔ ൌ ࢆࢻ/૛૛∗࢙ࢊ૛ࢊ૛  
sd = standard deviation; d = precision;	 
ࢆࢻ/૛ is the alpha level of significance = 1.96 at 5% level of significance 
Data management and statistical methods: 
Statistical Package for Social Sciences (SPSS) version 20.0 was used for data entry and 
analysis. Mean and standard deviation (SD) were calculated for quantitative variables (age, 
PTD, DTB, TIT, and all time intervals etc.) and proportions for categorical variables. All the 
baseline quantitative variables were compared across DTB, group wise (CPU group and 
Casualty group) using Mann Whitney U test. Bivariate and Multi-variate logistic regression 
analysis was performed to measure the association of each time variable with total DTB. 
Comparison between daytime /night-time DTB, Weekend vs. Weekday DTB and mode of 
payment was also done to see the difference in DTB if any using Fisher’s exact test. Odds 
ratio (OR) and 95% confidence intervals (CI) was calculated for these time intervals. P-value 
< 0.05 was considered as statistically significant. 
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Algorithm to calculate door to balloon time and factors causing delay > 90 min: 
 
 
 
                                                                                                  
         Pain to door time  
                                                                                                             (Window period)  
Delay in ECG                         
                                                      Casualty delay                                                                          
Delay in diagnosis 
 
Delay in decision by patient and relative(s)   & Finance related factors                                             
 
Delay in preparation  
                                                                                                                                                     DTB time     
Delay in Cath lab activation                                                                                                      
                                                                                                                              
Delay in transport  
 
Delay due to Cath lab busy  
Delay in vascular access   
Delay in crossing culprit lesion   
 
 
 
Patient with acute chest pain > 20 minutes suggestive of MI 
Non PCI Capable 
centre/Nursing 
home    CMCH  
                  Diagnosis of STEMI 
               Decision of Primary PCI 
     Casualty  
               Preparation of Patient 
              Cath lab activation 
Shifting patient to Cath lab 
          Vascular access  
           Crossing infarct related artery lesion by coronary guide wire 
   CPU 
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Observations and results  
Our Study included 96 patients of acute ST elevation myocardial infarction who underwent 
primary percutaneous coronary intervention at Christian Medical College & Hospital, Vellore 
(Tamil Nadu).Out of these 96 patients, 63 patients (65.6%) with symptoms suggestive of MI 
presented directly to Chest Pain Unit {CPU group} and remaining 33 patients (34.4%) 
presented initially to casualty and were shifted from there to cardiology department after 
evaluation in casualty {Casualty group}.  
Table 1- Group wise distribution of all study patients  
Group No. of Patients Percentage 
CPU group 63 65.6% 
Casualty group 33 34.4% 
Total  96 100% 
 
Out of these 96 patients, 46 patients had achieved door to balloon time ≤ 90 minutes and 
remaining 50 patients could not achieve the ideal of door to balloon time ≤ 90 minutes 
Table 2- Door to balloon time wise distribution of all study patients  
Door to time  No. of Patients Percentage 
≤ 90 minutes  46 47.9% 
>90 minutes  50 52.1% 
Total  96 100% 
 
                        
Figure 1   Proportion of patients in CPU & casualty group                     Figure 2 Proportion of patients based on DTB                                                     
CPU
group
Casualty
group
≤90 
minutes 
> 90
minutes
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Table 3- Baseline demographic Characteristics of Patients 
  
CPU group 
 
Casualty group 
 
 
P value 
 
Total 
 No. % No. %  No. % 
Age {Mean} years 58.2±12.5  54±10  0.10 56.8±12 
Sex (male) 53/63 84.1% 29/33 87.8% 0.61 82/96 85.4% 
Hypertension 30/63 47.6% 14/33 42.4% 0.62 44/96 45.8% 
DM 33/63 52.4% 16/33 48.5% 0.70 49/96 51.0% 
Hypercholesterolemia  36/63 57.1% 26/33 78.8% 0.03 62/96 64.5% 
Smoker 24/63 38.1% 12/63 36.4% 0.84 36/96 37.5% 
H/o CAD 10/63 15.9% 4/33 12.1% 0.59 14/96 14.5% 
H/o PAD 0/63 0% 2/33 6.1% 0.04 2/96 2.0% 
H/o CKD 1/63 1.6% 1/33 3% 0.64 2/96 2.0% 
H/O CVA 2/63 3.2% 3/33 9.1% 0.20 5/96 5.2% 
H/o prior 
PTCA/CABG 
3/63 4.7% 0/33 0% 0.20 3/96 3.1% 
Family H/o of IHD 8/63 12.6% 2/33 6.1% 0.31 10/96 10.4% 
BMI {Mean} Kg/m² 24.4±3.8 24.5±3.4 0.89 24.5±3.6 
 
In our Study, the mean age of overall patients was 56.8±12 years and MI in young (≤ 40 
years) occurred in 6 out of 96 patients (6.2%).There was predominance of males in our study 
which comprised of 85.4% patient population. Most of the patients [94 patients out of 96 
patients (97.9%)] had one or more coronary risk factors. The most common risk factor 
responsible for myocardial infarction in our study was hypercholesterolemia – which was 
observed in 64.5% patients, followed by diabetes mellitus & hypertension in 51% & in 
45.8% patients respectively. Family history of CAD was observed in 10.4 % of overall 
patients. 
In our study 37.5% patients had positive history of smoking (current and past). 
The Mean BMI of our study population was 24.5±3.6 Kg/m². 
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Table 5-Individual timings in CPU, Casualty group and total patients 
Time Interval CPU group Casualty group P value 
 
 
Total  
Time from arrival to ECG                                                                           
Mean ±SD 3.8±1.8minutes 7.3±7 minutes <0.001 4.9±4.6 minutes 
Median 3 minutes 5 minutes  5 minutes 
Range 1-8 minutes 2-44 minutes  1-44 minutes 
Time of ECG to Doctor’s evaluation and diagnosis time { of STEMI}   
Mean ±SD 5.8 minutes±9.8 5.1minutes±1.4 0.12 5.5±7.9 minutes 
Median 5 minutes 5 minutes  5 minutes 
Range 1-80 minutes 2-8 minutes  1-80 minutes 
Decision of and finance arrangement time   
Mean ±SD 24.7 ±13.9 minutes 22.4 ±11.9minutes 0.49 23.2±13.9 minutes 
Median 25 minutes 20 minutes  25 minutes 
Range 5-100 minutes 5-50 minutes  5-50 minutes 
Preparation time    
             Mean ±SD 14.2±5 minutes 12.7±4.7 minutes 0.19 13.7±4.9 minutes 
Median 15 minutes 15 minutes  15 minutes 
Range 5-28 minutes 5-25 minutes  5-28 minutes 
Transportation time   
Mean ±SD 10.3 ±5.4 minutes 10 ±2.5 minutes 0.77 10.1±4.5 minutes 
Median 10 minutes 10 minutes  10 minutes 
Range 4-45 minutes 5-15 minutes  4-45 minutes 
Cath lab entry to Vascular access time  
Mean ±SD 10.6 ±6.2 minutes 11.9 ± 9.4 minutes 0.78 11±7.4 minutes 
Median 10 minutes 10 minutes  10 minutes 
Range 5-40 minutes 5-40 minutes  5-40 minutes 
Vascular access to coronary guide wire passage time   
Mean ± SD 15.5 ±6.9 minutes 12.4 ±5.3 minutes 0.02 14.4±6.5 minutes 
Median 15 minutes 10 minutes  15 minutes 
Range 5-35 minutes 5-35 minutes  5-35 minutes 
Note: The various time intervals are dependent on 2-3 factors [e.g. It appears that the delay in 
vascular access time is purely due to time taken in getting the vascular access but vascular access 
time can be prolonged due to delayed shift of the patient to Cath lab table after entry to Cath lab 
which is usually related to busy Cath lab, hemodynamic in-stability & difficulty in getting vascular 
access etc].  
The mean time interval ± SD for overall cohort of patients [CPU vs. casualty group] showed 
that - mean ECG time was 4.9±4.6 minutes [3.8±1.8minutes vs. 7.3±7 minutes], mean 
diagnosis and evaluation time was 5.5±7.9 minutes [5.8±9.8 minutes vs. 5.1±1.4 minutes], 
mean decision and finance arrangement by patient and relatives was 23.2±13.9 minutes 
[24.7±13.9 minutes vs. 22.4±11.9 minutes], mean preparation time was 13.7±4.9 minutes 
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[14.2±5 minutes vs. 12.7±4.7 minutes], mean transportation time to Cath lab was 10.1±4.5 
minutes [10.3±5.4 minutes vs. 10±2.5 minutes], mean  vascular access time was 11±7.4 
minutes [10.6±6.2 minutes vs. 11.9±9.4 minutes], mean time taken for coronary guide wiring 
was 14.4±6.5 minutes [15.5 ±6.9minutes vs. 12.4±5.3 minutes] and the casualty delay was 
42.9± 19.8 minutes. ECG time and coronary wiring time were significantly different between 
the CPU and casualty group with p value of <0.001 and 0.02 respectively. Diagnosis and 
evaluation time, decision and finance arrangement time, preparation time, transportation time, 
vascular access time in the 2 groups were almost similar in both CPU and casualty group and 
there was no statistical significant difference in these timing among these groups. 
 
Figure 4– Mean times in minutes in CPU, casualty and over all patients. 
 
Total
CPU
Casualty
0 5 10 15 20 25 30 35 40 45 50
in minutes 
Casualty delay wiring time vascular access time
transporation time preparation time decision & finance time
Diagnosis time ECG time
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Table 6- Distribution of Door to Balloon time across all patients 
DTB CPU group 
 
Casualty group 
 
Total group 
         
n          % n % n % 
≤60 minutes 8/63 12.7% 0/33 0 8 8.3% 
61-90 minutes 34/63 54% 4/33 12.1% 38 39.6%
91-120 minutes 17/63 27% 13/33 39.4% 30 31.2%
≥121 minutes 4/63 6.3% 16/33 48.5% 20 20.9%
Total 63/63 100% 33/33 100% 96/96 100% 
                                                                                                         P value < 0.001 
42 patients out f 63 patients (66.7%) in CPU group, whereas only 4 patients out of 33 
patients (12.1%) in casualty group had achieved ideal DTB ≤ 90 minutes. The majority of 
casualty group patient had DTB > 90 minutes [In 48.5%, DTB was ≥121 minutes and in 
39.4%, DTB was 91-120 minutes] whereas majority of the CPU group patients had DTB ≤ 
90 minutes [In 54% DTB was between 61-90 minutes and in 12.7% DTB was ≤60 minutes].  
 
 
Figure 5 –Proportion of DTB times in patients within CPU and casualty group 
Figure shows that higher proportion of casualty patients had DTB > 90 minutes in 
comparison to CPU group patients & vice versa. 
60 min or less 61‐90 min 91‐120 min 121 min or more
Casualty
CPU
P value < 0.001
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Table9-Causes of delay in DTB in 50 patients 
 
Cause of delay 
CPU group 
 
Casualty group 
 
 
P value  
Total  
n = 23 % n = 56 % n = 79 % 
Patient related delay  12/23 52.2 21/56 36.8% 0.219 33/79 41.8% 
Casualty delay  0/23 0% 27/56 47.4% <0.001 27/79 34.2% 
Cath lab busy  3/23 13% 4/56 7% 0.391 7/79 8.8% 
Procedural delay  6/23 26.1% 1/56 1.8% <0.001 7/79 8.8% 
Hemodynamic 
instability  
1/23 4.3% 4/56 7% 0.613 5/79 6.2% 
Delay in diagnosis  1/23 4.3% 0/56 0% 0.118 1/79 1.2% 
Total  23/23 100% 56/56 100%  79/79 100% 
© Delay was defined with arbitrary value of 15 minutes or more, which lengthened the total DTB.  
In our study door to balloon time > 90 minutes was found in total 50 patients (21 out of 63 
patients in CPU group, and 29 out of 33 patients in casualty group).The overall 79 delays 
were related for delayed DTB > 90 minutes in those 50 patients with DTB > 90 min because 
–most of the patients had more than one cause of delay for door to balloon time, hence there 
were total of 79 delays which occurred in these 50 patients which had various combinations 
of delays or just one delay itself for delaying total door to balloon time > 90 minutes. {e.g. A 
patient having delay in DTB due to both casualty delay & procedural delay etc.}. 
The casualty delay and procedural delay {which includes time taken for vascular access and 
performing coronary angiography followed by successful coronary guide-wiring of the culprit 
lesion and this was statistically significant with P value 0.001 in CPU and Casualty group for 
delaying the Door to balloon time to > 90 minutes. The remaining all delays were not 
statistically significant between the 2 groups. 
The overall most common cause of delay in achieving door to balloon time was patient 
related delay {late patients decision with late finance arrangement} found in 41.8% of 
delays and followed by casualty delay which accounted for 34.2% of the delays overall seen 
in all patients who achieved door to balloon time > 90 minutes. Busy Cath lab and procedural 
delay both accounted for 8.8% each while hemodynamic instability was responsible for 6.2 % 
cause of delay in overall total patients who had door to balloon time > 90 minutes. The delay 
in diagnosis was observed in one patient only due to < 1 mm ST elevation with hyper acute T 
waves in the precordial leads V2-6 [which was repeated only after 80 minutes]. 
The most common cause of delay in door to balloon time > 90 min in CPU group was- 
patient related delay {late patients decision with late finance arrangement} which was 
found in 52.2% patients in this group and followed by procedural delay {difficulty in 
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hooking coronary artery or complex coronary anatomy with delayed coronary guide wire 
passage} which accounted for 26.1% of the delays in this group. The delay due to busy Cath 
lab was seen in three the patients and one patient had hemodynamic instability which delayed 
the door to balloon time. One patient had delay in diagnosis in due to ECG at presentation 
showing < 1 mm ST elevation with hyper acute T waves in the precordial leads V2-V6 
[which was repeated only after 80 minutes]. The most common cause of delay in door to 
balloon time > 90 min in casualty group was- casualty delay {delay in diagnosis, delayed 
information to cardiology department, time taken transporting the patient to CPU} which was 
found in 47.4% followed by patient related delay {late finance arrangement} which 
accounted for 36.8% of the delays. Four patients each had delayed DTB due to hemodynamic 
instability and busy Cath-lab. Only one patient had delay in door to balloon time due to 
procedural delay.  
 
 
Figure 10- Causes of DTB in CPU group, Casualty group and Overall patients with DTB > 90 minutes 
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Table 10 –Relation of DTB to day & time of PCI & to mode of payment 
 DTB ≤ 90 min 
 
DTB > 90 min  
P       
value 
 
Total 
n=46  
 
% n=50 % 
Day  
Weekday 38/85 
 
44.7% 47/85 55.3%  
0.080 
85/96 88.5%
Weekend 8/11 72.7% 3/11 27.3% 11/96 11.5%
Time of PCI  
8am to 8 pm  
 
33/65 50.8% 32/65 49.2%  
0.418 
65/96 67.7% 
8pm to 8 am 
  
13/31 41.9% 18/31 58.1% 31/96 32.3% 
Payment  
Self  28/56 50% 28/56 50%  
 
0.815 
56/96 58.3% 
Staff/Staff.dep 2/4 50% 2/4 50% 4/96 4.2% 
®TNCMCHIS 10/25 40% 15/25 60% 25/96 26% 
Insurance 6/10 60% 4/10 40% 10/96 10.4% 
Hospital free  0/1 0% 1/1 100% 1/96 1% 
® TNCMCHIS-Tamilnadu chief minister comprehensive health insurance scheme- free treatment by State 
government policy for the patients under below poverty line. 
 
 
Figure 11- Relation of DTB and day of PCI & time of PCI. 
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The mean DTB in patients presented on weekdays was 100.7 ± 30.4 minutes in compared to 
83.9± 29.5 minutes in patients presented on weekends but this did not reach the statistically 
significant P value {0.086} 
The mean DTB in patients presented between 8 am to 8 pm [Day time] was 97.9 ± 30 
minutes in compared to 100.6 ± 32.2 minutes in patients presented between 8 pm to 8 am        
[night-time], which was statistically not significant{P value 0.688}. 
Both of these comparisons were not statistically significant, however at our centre there is 
trend in having higher DTB when primary PCI was done in routine on weekdays but 
there was no statistical difference in DTB, whether presented during working hours or 
not.  
 
Figure 12- Relation of DTB and mode of payment   
DTB did not depend on payment mode of the patients (whether they are self paid, insurance 
paid, TNCMCHIS paid, Staff/staff dependent or they are treated under hospital free 
category).  
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Table 11-Clinical & ECG characteristics and LVEF across DTB 
Characteristics DTB 
≤ 90 minutes 
DTB 
>90  minutes 
 
 
P value 
 
Total n, (%) 
n =46 % n = 50 % n % 
Killip ’s  class  
I 41/46 89.1% 35/50 70%  
0.124 
76/96 79.2% 
II or more  5/46 10.9% 15/50 30% 20/96 20.8% 
Type of MI  
§AWMI 22/46 47.8% 27/50 54%  
0.492 
49/96 51.1% 
*IWMI 21/46 45.6% 23/50 46% 44/96 45.8% 
LWMI 3/46 6.5% 0/50 0% 3/96 3.1% 
% STR  
Complete  
{>70%} 
21/46 45.7% 16/50 32%  
0.031 
37/96 38.5% 
Partial {30-70%} 24/46 52.2% 25/50 50% 49/96 51.1% 
Absent      
{<30%} 
1/46 2.2% 9/50 28% 10/96 10.4% 
TIMI risk score  
0-7 40/46 87% 42/50 84%  
0.777 
82/96 85.4% 
8-14 6/46 13% 8/50 16% 14/96 14.6% 
#LVEF  
≤ 35 1/46 2.2% 8/50 16%  
0.058 
9/96 9.4% 
36-45 23/46 50% 24/50 48% 47/96 48.9% 
≥ 46 22/46 47.8% 18/50 36% 40/96 41.6% 
Note:  §AWMI included all STEMI with Antero-Septal MI, Extensive AWMI & Antero-lateral MI, * IWMI included all 
STEMI which involved inferior MI with or without Posterior MI or RV MI. # Echocardiography was performed in all 
patients immediately after the primary PCI at bedside {portable echo} and pre-discharge routine post PCI echo}.Those 
patients who could not be taken up for routine echo {expired before routine post PCI echo, bedside portable echo was used 
for analysis} 
79.2% ( 76 patients out of total 96) of our overall study patients were in Killip’s Class I at the 
time of admission and a higher proportion of the patients with Killip class II or more (20 out 
of  96 patients ) were observed in DTB > 90 minutes but this difference was not statistically 
significant . The most common type of MI in our study was AWMI (51.1%), closely 
followed by [IWMI (46%) with or without involvement of posterior wall MI or Right 
ventricular MI].The least common type (3.1%) of MI in our study was lateral wall MI. The 
MI type did not predict the DTB in our study. The patients with complete ST resolution 
proportion was higher in DTB ≤ 90 minutes group patients (45.7%)  in comparison to the 
DTB > 90 minutes group patients (32%) and this was statistically significant with P value of 
0.031.The TIMI risk score and LVEF by Echo in both groups were statistically in-significant 
both groups. 
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Table 12- Angiographic and procedural characteristics of patients across DTB 
Characteristics DTB 
≤ 90 minutes 
DTB 
>90  minutes 
 
P value  
 
Total n, (%) 
n=46 % n=50 %  N % 
Culprit vessel   
LAD/Diagonal 23 50% 27 54%  
0.926 
50 52.1% 
LCX/OM 4 8.7% 4 8% 8 8.3% 
RCA 19 41.3 19 38% 38 39.6% 
Type of CAD  
SVD 16 34.8% 27 54%  
 
0.226 
43 44.8% 
DVD 18 39.1% 10 20% 28 29.2% 
TVD 10 21.7% 9 18% 19 19.8% 
LM+DVD 1 2.2% 2 4% 3 3.1% 
LM+TVD 1 2.2% 2 4% 3 3.1% 
Access  
Radial  44 95.7% 38 76%  
0.023 
82 85.4% 
Femoral  2 4.3% 11 22% 13 13.5% 
RadialFemoral  0 0% 1 2% 1 1% 
TIMI flow pre  
0 & I 41 89.1% 47 94%  
0.388 
88 91.7% 
II or more 5 10.9% 3 6% 8 8.3% 
TIMI flow post  
  III  44 95.7% 45 90%  
0.287 
89 92.7% 
<III (No re-flow) 2 4.3% 5 10% 7 7.3% 
Use of Stents   
No Stent (POBA 
only) 
2 4.3% 7 14%  
 
0.067 
9 9.4% 
BMS 11 23.9% 18 36% 29 30.2% 
DES 33 71.7% 25 50% 58 60.4% 
Thrombus 
aspiration (%) 
37 80.4% 43 86% 0.534 80/96 83.3% 
Non-culprit artery 
PCI (%) 
2 4.3%         2 4% 0.932 4/96 4.2% 
Procedural 
complications (%) 
1 2.2% 2 4% 0.607 3/96 3.1% 
Use of (TPI) (%)  3 6.5% 8 16% 0.145 11/96 11.5% 
 
Overall most common Culprit artery responsible for STEMI in our study was LAD/Diagonal 
– which was seen in 50 patients out of 96 patient (52.1%) followed by RCA – which was 
 57 
 
Pa
ge5
7	
seen in 38 patients out of 96 patients (39.6%) and least common type of culprit artery was 
LCX/OM – which was seen only in 8 patients out of 96 patients (8.3%).Overall most 
common type of coronary artery disease in our study was Single vessel CAD- which was 
seen in 43 patients out of 96 patient (44.8%) followed by Double vessel CAD – which was 
seen in 28 patients out of 96 patients (28.2%) , followed by Triple vessel CAD- which was 
seen  in 19 patients out of 96 patients (19.8%). Left main Coronary artery disease (LM-CAD) 
was found in total 6 patients out 96 patients (6.2%).                                                                                           
In our study most of the patients had radial artery access for PCI 85.4 %, and remaining 
patient had femoral artery access for PCI. The proportion for radial access was higher in DTB 
≤ 90 minutes which was statistically different between the two DTB groups.  
Maximum number of the study patients 91.7% had Pre PCI TIMI flow grade of 0 & I. The 
TIMI flow had improved significantly in most of the patients after PCI 92.7% patients but 
no-reflow was observed in 7.3% of the patients. 
In our study most of the patients had undergone PCI with stent deployment (90.6%), rest of 
the 9.4 % patients received POBA only. There was higher proportion of DES usage (~72 %) 
in patients with DTB ≤ 90 minutes in comparison with DTB > 90 minutes group (50%), 
however this was not statistically significant . 
The thrombus aspiration using Export catheter was common in our study patients with overall 
83.3% patients underwent thrombectomy.  
The Non culprit artery PCI was considered only in ~ 4% of the study population in our study. 
The procedural complication occurred in 3 patients overall in our study (2 patients had 
coronary dissection during primary PCI and 1 patient had inadvertent stent dislodgement in 
the axillary artery while tracking, which required surgical intervention for retrieval of the 
dislodged stent). 
The use of trans-venous temporary pacemaker insertion was carried out in ~11.5 % of 
patients, which was not statistically significantly different in two DTB groups. 
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Table 13-Major adverse outcomes across DTB of all patients 
Characteristics  
DTB ≤ 90 min 
 
 
DTB >90 min  
 
P value 
 
Total n, (%) 
n = 46 % n = 50 %  n = 96 % 
In-hospital mortality 
 
0/46(0%) 4/50(8%)  
 
   0.050 
                   4/96(4.2%) 
Cardiogenic shock 0/46 0% 3/50 6% 3/96 3.1% 
Stent thrombosis 0/46 0% 0 0% 0/96 0% 
Other cause 0/46 0% 1/50 2% 1/96 1% 
Follow – up 
mortality within 30 
days 
1/46(2.1%) 1/50(2%)  
 
   0.952 
2/96(2.1%) 
Cardiogenic shock 0/46 0% 0/50 0% 0/96 0% 
Stent thrombosis 1/46 100% 1/50 100
% 
2/96 2.1% 
Overall mortality 
within 30 days of MI 
1/46(2.1%) 5/50(10%)  
 
 
0.114 
6/96(6.25%) 
Cardiogenic shock 0/46 0% 3/50 6% 3/96 3.1% 
Stent thrombosis 1/46 2.1% 1/50 2% 2/96 2.1% 
Other cause 0/46 0% 1/50 2% 1/96 1% 
CHF  
 
0 (0%) 1(2%)  
0.252 
1/96(1%) 
Stroke  
 
0(0%) 1(2%)  
0.252 
1/96(1%) 
Major Bleeding  0(0%) 0(0%) - 0(0%) 
 
MACCE rate 
 
 
1/46(2.1%) 
1/8[12.5%] 
 
7/50(14%) 
      7/8[87.5%] 
 
0.036 
 
8/96(8.3%) 
 
As shown in table-11, there were total 20 patients with admission Killip’s class II or more. [2 
patients of these 20 patients (in DTB> 90 minutes group) progressed to cardiogenic shock 
and they finally succumbed to in-hospital death due to cardiogenic shock. One of the patient 
out of 20 patients, had Killip’s class IV on admission (in DTB> 90 minutes group), who also 
did not survive [succumbed to in-hospital death due to cardiogenic shock].The survival rate at 
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discharge in primary PCI in Killip’s class II or more in 20 patients was 85% ( 17 patients 
survived out of 20 patients). 
Overall in our study there were 6 deaths {Overall mortality 6.25% in STEMI within 30 
days} –out of which 5 patients died in the patients with DTB > 90 minutes and 1 patient, died 
in with DTB ≤90 minutes. There was no in –hospital death in patients with DTB ≤ 90 
minutes but there were total 4 in-hospital deaths in the DTB > 90 minutes {3 patients, died of 
cardiogenic shock and fourth one died of non-cardiogenic shock}. The in-hospital mortality 
showed the trend towards lesser mortality in DTB ≤ 90 minutes with P value of 0.05.There 
were total 2 deaths after successful primary PCI and  discharge (30 day mortality) both of 
which were related due to stent thrombosis, and was equally present one patient in DTB ≤90 
and  > 90 minutes patients group. 
One patient in DTB > 90 minute group required readmission for acute precipitation of LV 
failure [recurrence of CHF] and was managed conservatively with optimization of medical 
management and survived initial 30 day duration. Another patient in DTB > 90 minute group 
had developed acute ischemic stroke which was also managed conservatively and survived 
initial 30 days of follow up.  
In our study TIMI major bleeding was not observed in any of the study patients. 
The MACCE rate in our study was 8.3%, majority (87.5%) of the events occurred in the DTB 
> 90 minutes (7/8 MACCE) and only 12.5 % (1/8 MACCE) events occurred in the DTB ≤ 90 
minutes. The difference in MACCE, between DTB groups was statistically significant with P 
value of 0.03. 
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Figure 13 – Major adverse cardiovascular and cerebrovascular events in respect to DTB 
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Discussion 
The mean age of presentation of STEMI patients undergoing primary PCI in the present study 
was 57±12 years. In the study of reperfusion trends in STEMI patients done by Kunwar et al 
(65), which included 1459 patients from 2008 to 2010 at CMC, Vellore and the CREATE 
registry (9) of acute coronary syndrome patients of India, which enrolled patients from 2001 
to 2005, the mean age was 56.3±11.8 years and 57.5±12 years respectively. This suggests 
that mean age for our study patients is similar to other study and registry from India. The 
patients enrolled in this presented a decade earlier than global data where mean age of 
STEMI presentation range from 64 to 69 years. Early age of presentation could lead to 
tremendous loss of productive years and has an adverse outcome on the economy as well as 
health of nation. In our study there was no correlation between age and gender of the patient 
on the DTB. In Study conducted by Sullivan et al has shown there was higher DTB in women 
and older patients and non chest pain presentation symptom patients. (66) 
In the present study women comprised only 14.6% of the all patients, which is also similar to 
proportion of women enrolled in CREATE registry (18%) and Kunwar et al (17%).This 
suggests that women in Indian STEMI studies receive inferior treatment than that of men. 
The most common risk factor responsible for myocardial infarction in our study was 
dyslipidaemia – which was observed in 64.5% patients, followed by diabetes mellitus & 
hypertension. In our study, family history of CAD and smoking was present in one tenth and 
one third   of the patients. 
In our study, the mean onset of symptoms to presentation time was ~ 5.2 hours {315.6 
minutes ± 260 minutes (range 30-1260 minutes) in comparison to 300 minutes in CREATE 
registry and 128-170 minutes from Global ACS registry and USA and European data for 
STEMI and mean total ischemia time in our study was ~ 6.9 hours {415.5 minutes±268 
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minutes (range 90-1350 minutes)}. This suggest that Indian patients in our study as well as 
from CREATE registry takes longer time to present to medical system after STEMI. 
 The mean door to balloon time {DTB} in all patients was 98.1 minutes (SD = 30.5 
minutes, median time = 93 minutes, range 50-200 minutes). The mean DTB in study 
conducted by Victor et al (67) was 80.5 min (SD = 34.4, median time 75 min, range 30–195) 
in the similar study done from India from Institute of cardiovascular diseases, Chennai. The 
mean DTB in study conducted at Karachi, Pakistan by Farman et al was 98.4 minutes(68). In 
our study, DTB ≤ 90 minutes occurred in 47.9% patients while DTB > 90 minutes occurred 
in 52.1% patients. In the study done at ICVD by Victor et al the DTB time was <90 min 
occurred in 76.5% and DTB time >90 min occurred in 23.5%.(67) 
Our study, to our Knowledge, is the first study from any institution in the Indian 
subcontinent which has tried to compare the STEMI patients’ based on based their 
presentation area–CPU vs. Casualty. Chest Pain Unit group {patients directly admitted to 
cardiac unit} and Casualty group {patients admitted to general emergency and from there 
rerouted to cardiac unit} of STEMI patients. This becomes more important in setting of busy 
casualty of Medical colleges which deals with all types of medical and surgical 
emergencies, where acute MI patients would be delayed of immediate evaluation and 
timely reperfusion therapy. The direct admission to Cath lab is associated with lesser DTB in 
study done by Luerent et al (69). 
The mean DTB in CPU group patients was 84.9 ± 22.1 minutes which was well within the 
international standards for primary PCI and mean DTB in casualty group was 123.4 ±28.5 
minutes and the difference was statistically significant with P value of <0.001. The ideal 
DTB ≤ 90 minutes was possible to achieve in 66.7 % in CPU group STEMI patients, in 
comparison to only 12.1 % of casualty group STEMI patients .This suggests that achieving 
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ideal DTB in an hospital setting with busy casualty is possible only when the patients are 
directly admitted to CPU rather than to casualty and from there rerouted to cardiology 
department. 
The mean time interval ± SD for overall cohort of patients [CPU vs. casualty group] showed 
that - mean ECG time was 4.9±4.6 minutes [3.8±1.8minutes vs. 7.3±7 minutes]. Mean ECG 
time in the study conducted by Phalen et al was 21.28 ±5.49 minutes, which was brought 
down to 9.47±2.48 minutes, after the intervention period (mandatory routine registration 
entry at triage) and this represented a 55% improvement in mean  door to ECG time(70). 
Mean diagnosis and evaluation time was 5.5±7.9 minutes [5.8±9.8 minutes vs. 5.1±1.4 
minutes],mean decision and finance arrangement by patient and relatives was 23.2±13.9 
minutes [24.7±13.9 minutes vs. 22.4±11.9 minutes], mean preparation time {Cath lab 
activation and premedication and consent for primary PCI time}was 13.7±4.9 minutes 
[14.2±5 minutes vs. 12.7±4.7 minutes],mean transportation time to was 10.1±4.5 minutes 
[10.3±5.4 minutes vs. 10±2.5 minutes], mean  vascular access time was11±7.4 
minutes[10.6±6.2 minutes vs. 11.9±9.4 minutes], mean time taken for coronary guide wiring 
was 14.4±6.5 minutes [15.5 ±6.9minutes vs. 12.4±5.3 minutes] and the casualty delay was 
42.9± 19.8 minutes. Similarly in study conducted by Victor et al (67) the Mean door to 
ECG – 6.5 min (SD = 2.7), mean time for the decision of PCI – 7.5 min (SD = 10.5), mean 
time taken for the patient's consent – 19.6 min (SD = 17.6), for STEMI team activation – 
6.7 min (SD = 7.6), average time for financial process – 39.2 min (SD = 22.9). Average time 
for sheath to balloon was 5.2 min (SD = 1.7). 
In our study there was no correlation between PTD and DTB, however study conducted by 
Ting et al showed that if there was longer delay in presentation after symptom onset, there 
was longer time to reperfusion therapy as well { both door to needle time and door to balloon 
time was higher }(71) 
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The Cath-lab activation at our centre is done by on call cardiology doctor rather by 
CMO [ Emergency room physician] .In the previous study done by Peterson et al has shown 
that STB is less if Cath lab activation is done by ER physician(60).  
The mean DTB in patients presented on weekdays was 100.7 ± 30.4 minutes in compared to 
83.9± 29.5 minutes in patients presented on weekends {P value 0.086]; Similarly the mean 
DTB in patients presented in Day time [between 8 am to 8 pm] was 97.9 ± 30 minutes in 
compared to 100.6 ± 32.2 minutes in patients presented in night-time [between 8 pm to 8 am 
{P value 0.688}]. Both of these comparisons were not statistically significant, however it is 
obvious that at our centre there is trend in having higher DTB when primary PCI was 
done in routine on weekdays and there was no statistical difference in DTB, whether 
presented during working hours or not. This reinforces that one of the chief cause of 
delay in DTB in our study is busy Cath lab.  In the  study done by Victor et al, at ICVD, 
Chennai showed that DTB did depend on whether the  patient presented in the morning hours 
or night hours for primary PCI (72). However the study done by Luerent et al (69) & Wu et 
al(73) showed that DTB was less in the cohort of patients who presented in the working hours 
of cardiac Cath lab rather than during on call hours. 
In our study, the novel analysis with regard to the effect of mode of payment on DTB was 
done and we found that there was no significant difference between payment mode [whether 
it is self paid or insurance paid or under free Govt. Scheme – TNCMCHIS or CMC hospital 
staff category] and DTB. 
Logistic regression by Multi-variate analysis shows that overall - ECG time, decision with 
finance arrangement time and vascular access time were the statistically significant factors 
which determined whether or not patient achieved DTB ≤90 minutes or not. The remaining 
all timings overall were statistically not significant for causing door to balloon time > 90 
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minutes. Logistic regression by Bi-Variate analysis shows that individually- ECG time, 
decision with finance arrangement time, transportation time, vascular access time and the 
casualty delay was statistically significant for causing the door to balloon time > 90 minutes. 
The remaining all timings individually were not statistically significant for causing door to 
balloon time > 90 minutes. 
To best of our knowledge, this is also the first study from India which has analyzed the 
Clinical and angiographic profile of STEMI patients undergoing primary PCI. 
There was no statistical difference in patients with type of MI (whether AWMI/IWMI or 
LWMI) and DTB (≤ 90 minutes vs. > 90 minutes) in our study. Overall most common 
Culprit artery responsible for STEMI in our study was LAD/Diagonal – which was seen 
52.1% followed by RCA –39.6% and least common type of culprit artery, was LCX/OM –
8.3%.Overall most common type of coronary artery disease in our study was Single vessel 
CAD- which was seen in 44.8% followed by Double vessel CAD – which was seen in 28.2%, 
followed by Triple vessel CAD- which was seen in 19.8%.Left main Coronary artery disease 
(LM-CAD) was found in 6.2%. 
The TIMI flow had improved significantly in most of our study population 92.7% and no-
reflow was observed in 7.3% of the patients.                       
In our study the in-hospital mortality was 4.2 % [4 deaths of the 96 patients] in total study 
cohort but there was no in-hospital death in DTB ≤ 90 minutes and all 4 patients died during 
index hospitalization, belonged to DTB > 90 minutes. There was trend towards the 
significance between in-hospital deaths and DTB in our study with P value 0.050. In the 
study done by Farman et al (68) In-hospital death was 5.7% , and in study done by Victor et 
al(67) it was 4.7% in overall study patients [ DTB < 90 minutes the in hospital mortality was 
3.1 % and DTB> 90 minutes it was 10% with p value of 0.2](67). 
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There is no Indian study compared the 30 days mortality in STEMI patients undergoing 
primary PCI. The overall 30 day mortality in our study was 6.25% (4.2 % due to in-hospital 
deaths and 2% due to stent thrombosis and fatal infarct).The 30 day mortality of STEMI 
patients in CREATE registry was 9% which included both type of reperfusion therapy of 
STEMI- thrombolytic and primary PCI(9). The total MACCE rate {death, CHF, recurrence 
of MI fatal or nonfatal, major bleeding or stroke} was 8.3% in our study. The MACCE rate 
was statistically significant between DTB > 90 minutes or DTB ≤ 90 minutes group with the 
p value of 0.036. The MACCE in our study included 6 deaths, 1 CHF and 1 Stroke. There 
was no patient with major bleeding or non fatal MI within 30 days in our STEMI study 
population. Out of 6 deaths [4 were in-hospital deaths, 2 deaths occurred on follow –up 
within 30 days both occurred due to stent thrombosis], one patient had CHF and other one 
patient developed acute ischemic stroke on follow up within 30 days of STEMI. The Killip’s 
class II or more was found in 20.8% [20 patients out of total 96 patients] on admission in our 
study patients. 2 patients with admission  Killip’s class II or III, progressed to cardiogenic 
shock & one patient who was in cardiogenic shock at the time of admission remained in 
cardiogenic shock despite primary PCI;  and all of three  patients of cardiogenic shock  died 
during index admission. 75% [3 deaths out of the 4] of the in-hospital deaths were related to 
cardiogenic shock and 25% [1 death out of the 4 deaths] deaths were not due to cardiogenic 
shock. There was higher mortality (10%) in DTB > 90 minutes in compared to 2.1% in DTB 
≤ 90 minutes, however there was no statistically significant difference between these groups. 
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LIMITATIONS 
1. The sample size is small [for mortality comparison between CPU and casualty groups    
large sample size is required] 
2. The time interval calculation was done retrospectively from doctor and nurses and 
Cath lab staff records, which can be inaccurate. [For exact calculation study 
coordinator may be required who can record these time intervals prospectively]. 
3. The various time intervals are dependent on 2-3 factors. 
4. There are no standard values of time intervals based on earlier studies.  
Strategies to improve Door to Balloon time at our centre: 
1. Uniform policy for treatment of STEMI especially not to delay the early 
thrombolysis rather than waiting for primary PCI, if there is expected delay is 
more than half an hour at any point of time. 
2. Guidelines for rapid assessment 
3. Use of Ambulance services [no. 108] to reach hospital rather than private 
vehicle- which ensures that all patients with symptoms suggestive of MI are 
triaged at CPU rather going to Casualty. 
4. Protocol for obtaining prompt repeat ECG – in view of doubtful ECG at 
presentation [repeat the ECG within 5-10 minutes for rapid diagnosis of 
STEMI] 
5. Process of performing primary PCI- A dedicated Cath lab with Cath lab 
team for primary PCI or rapid clearance of elective cases during routine work 
hours  
6. Prompt data feedback - routine data monitoring of performance with 
provision of prompt feedback, time-entry form & E-mail team members door-
to-balloon times after procedure [ timely inspection of DTB alliance] 
7. Senior management commitment Organizational environment with strong 
support by senior management as well as a culture that fosters and sustains 
organizational change directed at improving door to- balloon time  
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SUMMARY  
1. Mean age of STEMI patients undergoing primary PCI was 56.8 ±12 
years in this study of which 85.4% were male. 
2. Mean door to balloon time in our study was 98.1 ± 30.5 minutes in 
total study population. Overall 47.1% patients had achieved door to 
balloon time ≤ 90 minutes and remaining 52.1% patients could not 
achieve the ideal door to balloon time ≤ 90 minutes 
3. Mean DTB in CPU group was 84.9 ± 22.1 minutes in compared to 
123.4 ± 28.5 minutes in casualty group with P Value of <0.001. 
4. 66.7 % in CPU group patients achieved DTB ≤ 90 minutes in 
compared to only 12.1% patients in casualty group. The proportion of 
patients who had DTB > 90 minutes was higher in casualty group 
[87.9% vs. 33.3 %], when compared to CPU group. 
5. There was a trend towards higher DTB in the patients who presented 
on weekdays {Mean DTB on weekdays was 100.7 ± 30.4 minutes in 
compared to 83.9± 30.5 minutes on weekends [P value 0.086]}. 
6. There was no difference in DTB whether patients presented during 
daytime or night time {Mean DTB in day time was 97.9 ± 30 minutes 
in compared to 100.6 ± 32.2 minutes in night-time [P value 0.688]}. 
7. Bi-variate analysis shows that individually- ECG time, decision with 
finance arrangement time, transportation time, vascular access time 
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and the casualty delay were statistically significant factors for 
prolonged DTB. 
8. Multi-variate analysis shows that overall -ECG time, decision with 
finance arrangement time and vascular access time were the 
statistically significant factors for prolonged DTB. 
9. The most common cause of delay in door to balloon time to > 90 min 
in CPU group was patient related delay {late finance arrangement} 
which was found in 52.2% followed by procedural delay which 
accounted for 26.1%. 
10. The most common cause of delay in achieving door to balloon time to  
> 90 min in casualty group was casualty delay which was found in 
47.4% followed by patient related delay {late finance arrangement} 
which accounted for 36.8%.  
11. The overall most common cause of delay in achieving door to balloon 
time was patient related delay {late patients decision with late 
finance arrangement} found in 41.8% of delays and followed by 
casualty delay which accounted for 34.2% .Busy Cath lab and 
procedural delay both accounted for 8.8% each while hemodynamic 
instability was responsible for 6.2 % cause of delay in overall patients. 
The delay in diagnosis overall was seen in one patient. 
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12. The mean time ± SD [of various time variables], in the CPU and 
casualty groups showed that ECG time and coronary wiring time was 
significantly different in 2 group of patients. 
13. The most common type of MI in our study was AWMI (51%) and 
closely followed by [IWMI 46%- with or without involvement of 
posterior wall MI or Right ventricular MI]. 
14. Overall most common Culprit artery responsible for STEMI in our 
study was LAD/Diagonal. 
15. Overall most common type of coronary artery disease in our study was 
Single vessel CAD. 
16. Thrombectomy was performed in 83.3% of the patients. 
17. TIMI flow had improved significantly in most of the patients after PCI 
in 92.7% patients, and no-reflow was observed in 7.3% of the 
patients. 
18. In our study most of the patients had undergone PCI with stent 
deployment (90.6%), rest of the 9.4 % patients received only POBA. 
19. Overall in our study there were 6 deaths {Overall mortality 6.25% 
in STEMI within 30 days} –out of which 5 patients died in the patients 
with DTB > 90 minutes and 1 patient, died in with DTB ≤90 minutes. 
There were total 4 in-hospital deaths in the DTB > 90 minutes {3 
patients, died of cardiogenic shock and the fourth one died of non-
cardiogenic shock}. 
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20. There were 2 deaths after discharge (30 day mortality) both of which 
were related due to stent thrombosis, and was equally present one 
patient in both DTB group patients. 
21. One patient in DTB > 90 minute group had developed acute LV failure 
[recurrence of CHF] within initial 30 day duration of primary PCI. 
22. One patient in DTB > 90 minute group had developed acute ischemic 
stroke within 30 days of follow-up.  
23. In our study TIMI major bleeding was not observed in any of the study 
patients. 
24. The MACCE rate in our study was 8.3%. Majority [87.5%] of the 
events occurred in the DTB > 90 minutes (7/8 MACCE) and only 12.5 
% events occurred in DTB ≤ 90 minutes (1/8 MACCE). 
CONCLUSION 
The presentation of acute STEMI patients to Emergency department when 
compared with admission to CPU at Christian medical college and hospital, 
Vellore significantly delayed DTB. Apart from casualty delay the other causes 
for delay in DTB time in this study were delay due to late financial 
arrangement, and hemodynamic instability and busy Cath lab and procedural 
delay. 
 
 
 72 
 
Pa
ge7
2	
Bibliography 
 
1.  Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, editors. Global Burden of 
Disease and Risk Factors [Internet]. Washington (DC): World Bank; 2006 [cited 2014 
Jan 11]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK11812/ 
2.  Enas EA, Yusuf S. Third Meeting of the International Working Group on Coronary 
Artery Disease in South Asians. 29 March 1998, Atlanta, USA. Indian Heart J. 1999 
Feb;51(1):99–103.  
3.  Prevalence of coronary artery disease... [Indian Heart J. 2013 May-Jun] - PubMed - 
NCBI [Internet]. [cited 2014 Jan 9]. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/23809375 
4.  Shah B, Mathur P. Surveillance of cardiovascular disease risk factors in India: the need & 
scope. Indian J Med Res. 2010 Nov;132:634–42.  
5.  Alexander T, Mehta S, Mullasari A, Nallamothu BK. Systems of care for ST-elevation 
myocardial infarction in India. Heart Br Card Soc. 2012 Jan;98(1):15–7.  
6.  Enas EA, Dhawan J, Petkar S. Coronary artery disease in Asian Indians: lessons learnt 
and the role of lipoprotein(a). Indian Heart J. 1997 Feb;49(1):25–34.  
7.  Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: 
variations in cardiovascular disease by specific ethnic groups and geographic regions and 
prevention strategies. Circulation. 2001 Dec 4;104(23):2855–64.  
8.  Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, et al. The 
second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and 
outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart 
J. 2006 Oct;27(19):2285–93.  
9.  Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, et al. Treatment and 
outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of 
registry data. Lancet. 2008 Apr 26;371(9622):1435–42.  
10.  Vafaie M, Katus HA. [Myocardial infarction: New universal definition and its 
implementation in clinical practice]. Herz. 2013 Dec;38(8):821–7.  
11.  Cannon CP, Brindis RG, Chaitman BR, Cohen DJ, Cross JT Jr, Drozda JP Jr, et al. 2013 
ACCF/AHA key data elements and definitions for measuring the clinical management 
and outcomes of patients with acute coronary syndromes and coronary artery disease: a 
report of the American College of Cardiology Foundation/American Heart Association 
Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary 
Syndromes and Coronary Artery Disease Clinical Data Standards). Crit Pathw Cardiol. 
2013 Jun;12(2):65–105.  
12.  Sgarbossa EB, Pinski SL, Barbagelata A, Underwood DA, Gates KB, Topol EJ, et al. 
Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of 
 73 
 
Pa
ge7
3	
left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue 
Plasminogen Activator for Occluded Coronary Arteries) Investigators. N Engl J Med. 
1996 Feb 22;334(8):481–7.  
13.  Tubaro M, Danchin N, Goldstein P, Filippatos G, Hasin Y, Heras M, et al. Pre-hospital 
treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac 
Care of the European Society of Cardiology. Acute Card Care. 2011 Jun;13(2):56–67.  
14.  Gersh BJ, Stone GW, White HD, Holmes DR Jr. Pharmacological facilitation of primary 
percutaneous coronary intervention for acute myocardial infarction: is the slope of the 
curve the shape of the future? JAMA J Am Med Assoc. 2005 Feb 23;293(8):979–86.  
15.  Rathore SS, Curtis JP, Chen J, Wang Y, Nallamothu BK, Epstein AJ, et al. Association of 
door-to-balloon time and mortality in patients admitted to hospital with ST elevation 
myocardial infarction: national cohort study. BMJ. 2009;338:b1807.  
16.  Steg PG, James SK, Gersh BJ. 2012 ESC STEMI guidelines and reperfusion therapy: 
Evidence-based recommendations, ensuring optimal patient management. Heart Br Card 
Soc. 2013 Aug;99(16):1156–7.  
17.  Sikri N, Bardia A. A history of streptokinase use in acute myocardial infarction. Tex 
Heart Inst J Tex Heart Inst St Lukes Episcop Hosp Tex Child Hosp. 2007;34(3):318–27.  
18.  Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and 
prehospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA J Am 
Med Assoc. 2000 May 24;283(20):2686–92.  
19.  Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP, Dubien PY, et al. 
Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a 
randomised study. Lancet. 2002 Sep 14;360(9336):825–9.  
20.  Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic 
therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. 
Lancet. 2003 Jan 4;361(9351):13–20.  
21.  Nunn CM, O’Neill WW, Rothbaum D, Stone GW, O’Keefe J, Overlie P, et al. Long-term 
outcome after primary angioplasty: report from the primary angioplasty in myocardial 
infarction (PAMI-I) trial. J Am Coll Cardiol. 1999 Mar;33(3):640–6.  
22.  Rott D, Behar S, Gottlieb S, Boyko V, Hod H. Usefulness of the Killip classification for 
early risk stratification of patients with acute myocardial infarction in the 1990s 
compared with those treated in the 1980s. Israeli Thrombolytic Survey Group and the 
Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group. Am J 
Cardiol. 1997 Oct 1;80(7):859–64.  
23.  Forrester JS, Diamond G, Chatterjee K, Swan HJ. Medical therapy of acute myocardial 
infarction by application of hemodynamic subsets (first of two parts). N Engl J Med. 
1976 Dec 9;295(24):1356–62.  
24.  Forrester JS, Diamond G, Chatterjee K, Swan HJ. Medical therapy of acute myocardial 
infarction by application of hemodynamic subsets (second of two parts). N Engl J Med. 
1976 Dec 16;295(25):1404–13.  
 74 
 
Pa
ge7
4	
25.  DeGeare VS, Boura JA, Grines LL, O’Neill WW, Grines CL. Predictive value of the 
Killip classification in patients undergoing primary percutaneous coronary intervention 
for acute myocardial infarction. Am J Cardiol. 2001 May 1;87(9):1035–8.  
26.  Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. 
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical 
score for risk assessment at presentation: An intravenous nPA for treatment of infarcting 
myocardium early II trial substudy. Circulation. 2000 Oct 24;102(17):2031–7.  
27.  Abelin AP, David RB, Gottschall CA, Quadros AS. Accuracy of dedicated risk scores in 
patients undergoing primary percutaneous coronary intervention in daily clinical practice. 
Can J Cardiol. 2014 Jan;30(1):125–31.  
28.  Kozieradzka A, Kamiński K, Dobrzycki S, Nowak K, Musiał W. TIMI Risk Score 
accurately predicts risk of death in 30-day and one-year follow-up in STEMI patients 
treated with primary percutaneous coronary interventions. Kardiol Pol. 2007 
Jul;65(7):788–795; discussion 796–797.  
29.  Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, et al. Long-
term benefit of primary angioplasty as compared with thrombolytic therapy for acute 
myocardial infarction. N Engl J Med. 1999 Nov 4;341(19):1413–9.  
30.  De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann F-J, et al. 
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation 
myocardial infarction: a meta-analysis of randomized trials. JAMA J Am Med Assoc. 
2005 Apr 13;293(14):1759–65.  
31.  Nordmann AJ, Hengstler P, Harr T, Young J, Bucher HC. Clinical outcomes of primary 
stenting versus balloon angioplasty in patients with myocardial infarction: a meta-
analysis of randomized controlled trials. Am J Med. 2004 Feb 15;116(4):253–62.  
32.  Stone GW, Brodie BR, Griffin JJ, Costantini C, Morice MC, St Goar FG, et al. Clinical 
and angiographic follow-Up after primary stenting in acute myocardial infarction: the 
Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial. Circulation. 1999 
Mar 30;99(12):1548–54.  
33.  Stone GW, Clayton T, Deliargyris EN, Prats J, Mehran R, Pocock SJ. Reduction in 
Cardiac Mortality With Bivalirudin in Patients With and Without Major Bleeding: The 
HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in 
Acute Myocardial Infarction). J Am Coll Cardiol. 2014 Jan 7;63(1):15–20.  
34.  Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, et al. Meta-
analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with 
acute myocardial infarction. Eur Heart J. 2007 Nov;28(22):2706–13.  
35.  Vlaar PJ, Mahmoud KD, Holmes DR Jr, van Valkenhoef G, Hillege HL, van der Horst 
ICC, et al. Culprit vessel only versus multivessel and staged percutaneous coronary 
intervention for multivessel disease in patients presenting with ST-segment elevation 
myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol. 2011 
Aug 9;58(7):692–703.  
 75 
 
Pa
ge7
5	
36.  Hannan EL, Samadashvili Z, Walford G, Holmes DR Jr, Jacobs AK, Stamato NJ, et al. 
Culprit vessel percutaneous coronary intervention versus multivessel and staged 
percutaneous coronary intervention for ST-segment elevation myocardial infarction 
patients with multivessel disease. JACC Cardiovasc Interv. 2010 Jan;3(1):22–31.  
37.  Jolly SS, Cairns J, Yusuf S, Niemela K, Steg PG, Worthley M, et al. Procedural Volume 
and Outcomes with Radial or Femoral access for coronary angiography and intervention. 
J Am Coll Cardiol. 2013 Nov 6;  
38.  Lee MS, Wolfe M, Stone GW. Transradial versus transfemoral percutaneous coronary 
intervention in acute coronary syndromes: re-evaluation of the current body of evidence. 
JACC Cardiovasc Interv. 2013 Nov;6(11):1149–52.  
39.  O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: 
executive summary: a report of the American College of Cardiology 
Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 
2013 Jan 29;127(4):529–55.  
40.  Bahekar A, Singh M, Singh S, Bhuriya R, Ahmad K, Khosla S, et al. Cardiovascular 
outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or 
without cardiogenic shock: a meta-analysis. J Cardiovasc Pharmacol Ther. 2012 
Mar;17(1):44–56.  
41.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study 
Group. N Engl J Med. 1985 Apr 4;312(14):932–6.  
42.  Eeckhout E, Kern MJ. The coronary no-reflow phenomenon: a review of mechanisms 
and therapies. Eur Heart J. 2001 May;22(9):729–39.  
43.  Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es G-A, et al. Clinical end 
points in coronary stent trials: a case for standardized definitions. Circulation. 2007 May 
1;115(17):2344–51.  
44.  McCullough P. Outcomes of contrast-induced nephropathy: experience in patients 
undergoing cardiovascular intervention. Catheter Cardiovasc Interv Off J Soc Card 
Angiogr Interv. 2006 Mar;67(3):335–43.  
45.  Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk 
score for prediction of contrast-induced nephropathy after percutaneous coronary 
intervention: development and initial validation. J Am Coll Cardiol. 2004 Oct 
6;44(7):1393–9.  
46.  Gershlick AH, Banning AP, Myat A, Verheugt FWA, Gersh BJ. Reperfusion therapy for 
STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary 
intervention? Lancet. 2013 Aug 17;382(9892):624–32.  
47.  Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Andersen HR, et al. 1-
year survival in a randomized trial of facilitated reperfusion: results from the FINESSE 
(Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial. JACC 
Cardiovasc Interv. 2009 Oct;2(10):909–16.  
 76 
 
Pa
ge7
6	
48.  Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous 
Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-
facilitated percutaneous coronary intervention in patients with ST-segment elevation 
acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet. 2006 Feb 
18;367(9510):569–78.  
49.  Carver A, Rafelt S, Gershlick AH, Fairbrother KL, Hughes S, Wilcox R, et al. Longer-
term follow-up of patients recruited to the REACT (Rescue Angioplasty Versus 
Conservative Treatment or Repeat Thrombolysis) trial. J Am Coll Cardiol. 2009 Jul 
7;54(2):118–26.  
50.  Atar S, Barbagelata A, Birnbaum Y. Electrocardiographic markers of reperfusion in ST-
elevation myocardial infarction. Cardiol Clin. 2006 Aug;24(3):367–376, viii.  
51.  Nallamothu BK, Wang Y, Bradley EH, Ho KKL, Curtis JP, Rumsfeld JS, et al. 
Comparing hospital performance in door-to-balloon time between the Hospital Quality 
Alliance and the National Cardiovascular Data Registry. J Am Coll Cardiol. 2007 Oct 
9;50(15):1517–9.  
52.  Georges J-L, Ben-Hadj I, Gibault-Genty G, Blicq E, Aziza J-P, Ben-Jemaa K, et al. 
[Accuracy of the door-to-balloon time for assessing the result of the interventional 
reperfusion strategy in acute ST-segment elevation myocardial infarction]. Ann Cardiol 
Angéiologie. 2011 Nov;60(5):244–51.  
53.  Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, et al. 
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality 
in patients undergoing angioplasty for acute myocardial infarction. JAMA J Am Med 
Assoc. 2000 Jun 14;283(22):2941–7.  
54.  McNamara RL, Wang Y, Herrin J, Curtis JP, Bradley EH, Magid DJ, et al. Effect of 
door-to-balloon time on mortality in patients with ST-segment elevation myocardial 
infarction. J Am Coll Cardiol. 2006 Jun 6;47(11):2180–6.  
55.  Boersma E, Primary Coronary Angioplasty vs. Thrombolysis Group. Does time matter? 
A pooled analysis of randomized clinical trials comparing primary percutaneous coronary 
intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart 
J. 2006 Apr;27(7):779–88.  
56.  Menees DS, Peterson ED, Wang Y, Curtis JP, Messenger JC, Rumsfeld JS, et al. Door-
to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med. 
2013 Sep 5;369(10):901–9.  
57.  McCabe JM, Armstrong EJ, Hoffmayer KS, Bhave PD, MacGregor JS, Hsue P, et al. 
Impact of door-to-activation time on door-to-balloon time in primary percutaneous 
coronary intervention for ST-segment elevation myocardial infarctions: a report from the 
Activate-SF registry. Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):672–9.  
58.  Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, et al. Hospital 
delays in reperfusion for ST-elevation myocardial infarction: implications when selecting 
a reperfusion strategy. Circulation. 2006 Nov 7;114(19):2019–25.  
 77 
 
Pa
ge7
7	
59.  Luepker RV, Raczynski JM, Osganian S, Goldberg RJ, Finnegan JR Jr, Hedges JR, et al. 
Effect of a community intervention on patient delay and emergency medical service use 
in acute coronary heart disease: The Rapid Early Action for Coronary Treatment 
(REACT) Trial. JAMA J Am Med Assoc. 2000 Jul 5;284(1):60–7.  
60.  Peterson MC, Syndergaard T, Bowler J, Doxey R. A systematic review of factors 
predicting door to balloon time in ST-segment elevation myocardial infarction treated 
with percutaneous intervention. Int J Cardiol. 2012 May 17;157(1):8–23.  
62.  Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, et al. 
Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 
2006 Dec 7;355(23):2395–407.  
63.  Widimsky P, Fajadet J, Danchin N, Wijns W. “Stent 4 Life” targeting PCI at all who will 
benefit the most. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC 
Working Group on Acute Cardiac Care. EuroIntervention J Eur Collab Work Group 
Interv Cardiol Eur Soc Cardiol. 2009 Mar;4(5):555, 557.  
65.  Kunwar BK, Hooda A, Joseph G. Recent trends in reperfusion in ST elevation 
myocardial infarction in a South Indian tier-3 city. Indian Heart J. 2012 Jul;64(4):368–73.  
66.  Sullivan AL, Beshansky JR, Ruthazer R, Murman DH, Mader TJ, Selker HP. Factors 
associated with longer time to treatment for patients with suspected acute coronary 
syndromes: a cohort study. Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):86–94.  
67.  Door-to-balloon: where do we lose tim... [Indian Heart J. 2012 Nov-Dec] - PubMed - 
NCBI [Internet]. [cited 2014 Jan 6]. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/23253411# 
68.  Farman MT, Sial JA, Khan NU, Rizvi SNH, Saghir T, Zaman KS. Outcome of primary 
percutaneous coronary intervention at public sector tertiary care hospital in Pakistan. 
JPMA J Pak Med Assoc. 2011 Jun;61(6):575–81.  
69.  Leurent G, Fougerou C, Pennec P-Y, Filippi E, Moquet B, Druelles P, et al. Door-to-
balloon delays before primary angioplasty in the Regional Acute Myocardial Infarction 
Registry of Brittany. An analysis of the Observatoire Régional Breton sur l’Infarctus du 
myocarde (ORBI). Arch Cardiovasc Dis. 2009 Nov;102(11):777–84.  
70.  Phelan MP, Glauser J, Smith E, Martin C, Schrump S, Mahone P, et al. Improving 
emergency department door-to-electrocardiogram time in ST segment elevation 
myocardial infarction. Crit Pathw Cardiol. 2009 Sep;8(3):119–21.  
71.  Ting HH, Bradley EH, Wang Y, Nallamothu BK, Gersh BJ, Roger VL, et al. Delay in 
presentation and reperfusion therapy in ST-elevation myocardial infarction. Am J Med. 
2008 Apr;121(4):316–23.  
73.  Wu EB, Arora N, Eisenhauer AC, Resnic FS. An analysis of door-to-balloon time in a 
single center to determine causes of delay and possibilities for improvement. Catheter 
Cardiovasc Interv Off J Soc Card Angiogr Interv. 2008 Feb 1;71(2):152–7.  
  
 78 
 
Pa
ge7
8	
Appendix	I	
Proforma 
 Case no. 
Date:                                                                                              Time of admission      :                                  
NAME:                                        
AGE:                           SEX:                Ht.  :                    Wt.:                        BMI:                 
HOSPITAL NO.:  
Address:                                                                                                        Contact no. :   
 
Risk factor 
 
HTN 
 
DM 
 
DL 
 
Current  
or 
Ex Smk 
 
Prior CAD/ACS/MI 
 
Prior PTCA  / 
CABG 
 
CKD 
 
PAD 
 
CVA 
 
Fam 
CAD 
Yes/no          
Dur                           
 
Presenting complaints: 
1. Chest pain:            Mins            2. Dyspnoea:              Min        3. Others:  
Pain to door time (Window Period): 
Exam, n:         Pulse:                                       BP:                         CVS:                      RS:       Killip’s 
class  
ECG  STE leads   Max STE 
lead  
ST80     Rate  / Rhythm          Cond. Abn               STR 
Pre PCI                      NA
Post PCI         
 
Door to Balloon time:                  
 CPU/ 
Casualty  
 Time to 
first ECG 
Diagnosis time   Finance 
arrangeme
nt time  
Preparation 
time   
 Transport 
time    
Vascular 
access 
time  
Wiring 
time   
CD 
if 
any  
Time       
Min.      
 
TIT in mins: PTD+DTB 
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Access site:                Radial / Femoral 
Angiographic profile:  CAD – SVD/DVD/TVD/ LM+TVD, Occlusion in: Proximal / mid /Distal   
Infarct related artery:   LM/ LAD /RCA/RI/ LCx/ D1/D2/D3/Septal branch of LAD/ 
OM1/OM2/OM3/AM/RPDA/LPDA/ RPLB/LPLB.  
Pre PCI TIMI flow:  
Use of thrombus aspiration by export catheter (YES/NO) or Clearway catheter (YES/NO) 
Pre PCI Balloon :     Yes / No  
No.      Type                          Size                       Pressure 
       
Stent :                   
Type   /    Platform  /  Polymer  / Drug                   Name                    Size Pressure
             
             
Post PCI Balloon: Yes/No  
No.      Type                          Size                       Pressure 
       
       
Use of drugs during pPCI: 
Drugs during PCI        I/v Heparin  IntracoronaryNTG  Intraco. Adenosine  Intracor.Tirofiban 
Dose      
 
Any other treatment required:  
Final TIMI flow [Post PCI TIMI flow] : 
TIMI risk score:                                          
Post procedure complications: Vascular site bleeding / other bleeding /Contrast reaction 
/CIN / Stent thrombosis/ death. 
Investigations: 
Parame
ter  
H
b. 
Pla
tel
ets  
Crea
t 
eGF
R  
CKMB  TrT/I N
a 
K Lipids 
CH/TG/HDL/LDL 
AC PC  HbA1
c 
TSH
At 
PCI   
                               
 
ECHO : ( before discharge )  
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1 RWMA:  LV RWMA ‐ Anterior wall / Inferior wall / Posterior wall / Lateral wall  
                    RV free wall  
                    Septum / Anterior septum.  
‐ Normal contractility /Hypokinesia / Akinesia / dyskinesia / aneurysm  
2 LVEF  
3 . Any mechanical Complications – if any specify. 
Follow up at 30 days:  
1. Patient Alive or death 
  If died due to Cardiovascular cause specify or No cardiovascular death or unknown.   
‐ in hospital mortality or death within 30 day 
2    Any recurrence of rest angina or AOE / heart failure / admission for cardiovascular     
cause or Recurrence of MI / Stent thrombosis. 
 
3Clinical examination  
 
      4.   ECHO if done again at 30 days. 
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Appendix	II	
	
PATIENT INFORMATION SHEET 
Introduction:  
The heart is made of muscle, and has three arteries which supply oxygenated blood 
for its nutrition, which are known as coronary arteries. Atherosclerosis is a disease of these 
arteries which leads to obstruction to flow in these arteries .Atherosclerosis  is predisposed 
by several risk modifiable risk factors like high  blood pressure (hypertension) , High sugars 
(diabetes mellitus)  ,High  cholesterol  levels  (hyperlipidemia)  ,sedentary  lifestyle  ,smoking  
and  few non modifiable  risk  factors  ‐ male  sex and older age  .Heart attack occurs due  to  
abrupt    rupture of  atherosclerotic plaque    leading  to occlusion of  culprit  coronary  artery 
completely. Heart attack usually causes acute severe chest pain persisting for more than 20 
minutes associated with sweating & breathlessness. This chest pain  is also associated with 
radiation of pain  to  left arm. Heart attack  leads  to cessation of blood supply  to  the heart 
muscle leading to death of the heart muscle (myocardium). 
The  aim  of  treatment  in  acute  heart  attack  is  to  restore  the  blood  supply  to  the 
jeopardized myocardium. There are two basic modality to restore the blood supply in heart 
attack  situation either medicines which dissolves  the  clot  in  the  coronary artery or doing 
emergency  angioplasty.  The  best  treatment  in  heart  attack  (STEMI)  is  to  perform  timely 
angioplasty‐ a minor operation done percutaneously to open the blocked coronary artery. 
The  angioplasty  done  with  out  prior  thrombolysis  is  known  as  primary  angioplasty  or 
primary percuataneous coronary intervention              (pPCI ). 
Aim of our study:  
We are doing the study of STEMI (heart attack) patients presenting to CMCH, Vellore  
and  undergoing    primary  angioplasty  as  treatment  option. We will  record  your  detailed 
medical history and record the Pain to door time or window period ‐ time of onset of pain 
to hospital arrival time, Door to balloon time – time of hospital arrival to crossing the culprit 
lesion by coronary guide wire. The sum of both the time  is known as total  ischemia time. 
The  lesser  the  time  taken  for patient  to undergo primary PCI,  lesser  the damage  to heart 
muscle. The door to balloon time should be < 90 minutes according to recent guidelines.  
The  primary  objective  of  the  study  is  to  assess  the  door  to  balloon  time  in  our  STEMI 
patients and to study the causes of delay in door to balloon time. 
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Appendix	III	
Informed Consent form to participate in a research study 
Study Title: “Door to balloon time (DTB) in ST elevation Myocardial Infarction (STEMI) 
patients -the efficiency of Primary percutaneous coronary intervention system-Where 
do we stand? A large tertiary care hospital study from India” Study Number: 8106  
Subject’s Initials: _________                                Subject’s Name: ________ 
Date of Birth / Age:_____ 
 (i)  I confirm  that  I have  read and understood  the  information sheet dated _________  for 
the above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or  legal 
rights being affected. [ ] 
 (iii)  I  understand  that  the  Sponsor  of  the  clinical  trial,  others working  on  the  Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission to 
look at my health records both in respect of the current study and any further research that 
may be conducted  in relation to  it, even  if  I withdraw from the trial.  I agree to this access. 
However, I understand that my identity will not be revealed in any information released to 
third parties or published. [ ] 
(iv) I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
Signature  (or  Thumb  impression)  of  the  Subject/Legally  Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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Appendix	IV	
Glossary and Abbreviations 
Group.no.1: patients presented to casualty 
Group. No.2: patients presented to CPU 
H.no. hospital number 
s.no: serial number 
HTN: Hypertension  
DM: Diabetes mellitus 
DLP: Dyslipidaemia  
Smk: Smoker 
CAD: Coronary artery disease  
CKD: Chronic kidney disease  
CVA: Cerebro-vascular accident  
PAD: peripheral arterial disease  
P/C: P- PTCA: Percutaneous transluminal angioplasty; c- CABG: Coronary artery by-pass 
graft 
Fam: Family history of IHD 
BMI: Body mass index 
PTD: pain to door time 
ECG: time taken for first ECG with ST elevation  
Diag: Diagnosis and evaluation time 
Deci: decision and finance arrangement time  
Ppn: Preparation time  
Tr: transportation time  
Vasc: Vascular access time  
Wire: coronary wiring time  
CD: casualty delay  
DTB: Door to Balloon time  
TIT: total ischemia time  
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COD: Cause of delay  
1) Casualty delay 
2) Hemodynamic instability  
3) Cath lab busy 
4) Patient related delay  
5) Procedural delay 
6) Other  
AW: Anterior wall MI  
IW: Inferior wall MI 
IWPW: Inferior wall + posterior wall MI 
IWRV: Inferior wall MI+RVMI 
IWPWRV: inferior wall + Posterior wall and RV MI 
LW: Lateral wall MI 
HR: Heart rate 
SBP: Systolic blood pressure  
K: Killip, s class  
% STR: Percentage ST resolution 1-complete; 2-partial; 3- absent  
Arr: arrhythmia, chb: complete heart block; 1HB-first degree heart block; 2 HB- second 
degree heart block ,qRBBB: q Right bundle branch block , LBBB: Left bundle branch 
block,VT:ventricular tachycardia , Vtrig: ventricular trigeminy; apc: atrial premature 
contraction ; vpc: ventricular premature contraction  ; JR: junctional rhythm. 
TPI: Temporary Pacemaker insertion  
R/F: R-radial access; F- femoral access  
SVD: Single vessel coronary artery disease  
DVD: Double vessel coronary artery disease  
TVD: Triple vessel coronary artery disease  
LM+DVD: Left main + double vessel coronary artery disease  
LM+TVD: Left main + triple vessel coronary artery disease 
Culpar: Culprit artery  
LAD: Left anterior descending artery  
LCx: Left Circumflex artery  
RCA: Right Coronary artery 
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RPDA: Right posterior descending artery 
RPLB: right poster lateral branch of LV  
P- Proximal; m-mid; d-distal  
pTIMI: Pre PCI TIMI flow grade  
TIMIp: post PCI TIMI flow grade 
Thrasp: Thrombus aspiration  
DES: drug eluting stent; BMS: Bare-metal stent; 0- No stent only POBA-Plain old balloon 
angioplasty 
Noncul: non - culprit artery PCI 
Pro Comp: Procedural complication 1a- coronary artery dissection; 1b- coronary stent 
dislodgement  
TIMI risk: TIMI risk score  
LVEF: LV ejection fraction  
C.Vol: Contrast volume  
CIN: Contrast induced nephropathy  
Tzone 1- 8am to 8 pm; 2- 8 pm to 8 am 
Day 1 –Monday; 2-Tuesday; 3-Wednesday;4-Thursday;5-Friday;6-Saturday;7-sunday  
Hosp o: hospital outcome A-alive; E-expired, ECS-expired due to cardiogenic shock 
30d o: 30 day outcome A-alive-expired, ECS-expired due to cardiogenic shock, ST: stent 
thrombosis  
Payment- 1: Self; 2: staff/staff dependent; TNCMCHIS: Tamil nadu chief minister 
comprehensive health insurance scheme; 4- insurance; 5-hospital free  
ECG: electrocardiogram  
Min: minutes 
SD: standard deviation  
CI: confidence interval  
HsCRP: Highly sensitive C reactive protein 
Lp (a): Lipoprotein (a) 
CVD: Cardiovascular disease  
S.no grno Hosp.no. sex age HTN DM DLP Smk CAD PAD CKD CVA P/C Fam IHD BMI PTD ecg Diag deci ppn tr vasc wire CD DTB TIT COD MI HR SBP k
1 2 288407F 1 48 0 0 1 0 0 0 0 0 0 1 23.4 180 3 2 5 10 10 5 11 30 76 256 0 AW 95 160 1
2 2 287354F 1 52 1 1 1 0 0 0 0 0 0 1 22.2 420 5 3 17 15 15 10 15 25 105 525 1,2,3,4 IWRV 40 90 1
3 2 286849F 1 46 1 0 1 1 1 1 1 1 0 0 21.1 225 5 5 13 20 15 5 15 15 93 318 1 AW 70 160 1
4 2 295626F 1 50 0 1 1 0 0 0 0 0 0 0 25.5 510 4 6 25 15 10 10 10 30 110 620 1,2,4 IWPWRV 72 100 1
5 2 058546F 1 43 1 0 1 1 0 0 0 1 0 0 26.4 600 5 5 15 20 10 10 9 45 119 719 1 AW 86 110 1
6 2 327307F 1 42 0 0 1 1 0 0 0 0 0 0 23.4 580 12 8 5 15 5 5 10 30 90 665 0 IWRV 71 140 1
7 2 322632F 1 58 0 0 1 1 0 0 0 0 0 0 31.2 120 4 6 10 15 10 5 10 20 80 200 0 IWPWRV 60 90 1
8 2 322636F 1 47 0 0 1 0 0 0 0 0 0 0 27.7 330 8 2 5 25 10 40 10 30 130 460 3 AW 75 108 1
9 2 322650F 1 45 0 0 1 1 0 0 0 0 0 0 19.5 450 11 4 30 5 15 10 20 45 140 570 1,4,5 IWPW 75 130 1
10 2 168166F 1 37 0 0 1 1 0 0 0 0 0 0 31.2 120 5 5 30 10 10 10 10 40 120 240 1,4 AW 80 136 2
11 2 *021711 2 69 1 1 1 0 0 0 0 0 0 0 21.6 480 5 5 5 15 5 10 10 45 100 580 1 AW 90 110 2
12 2 331256F 2 52 0 1 1 0 0 0 0 0 0 0 18.9 160 5 5 15 10 10 10 10 25 90 260 0 AW 78 110 1
13 2 331534F 1 52 1 1 0 0 0 0 0 0 0 0 26.1 160 5 5 30 10 10 10 20 40 130 290 4 AW 90 130 1
14 2 338794F 1 70 0 1 0 0 0 0 0 0 0 0 28.1 360 5 5 10 10 5 10 15 45 105 465 1 AW 69 120 3
15 2 338546F 1 47 0 0 1 1 0 0 0 0 0 0 21 410 10 5 35 10 10 10 10 40 130 540 1,4 AW 98 100 1
16 2 341764F 1 36 0 1 1 1 0 0 0 0 0 0 22.1 360 5 5 30 20 10 5 10 40 125 485 1,4 AW 106 110 1
17 2 799760D 1 54 0 0 0 1 0 0 0 0 0 0 26 345 6 5 24 15 10 10 15 50 135 480 1,4 AW 82 160 1
18 2 558059D 1 67 1 1 1 0 0 0 0 0 0 0 24.4 800 6 4 50 10 10 10 15 40 145 945 1,4 AW 103 150 3
19 2 411056D 1 46 1 1 1 0 1 0 0 0 0 0 22.8 175 4 6 35 15 10 10 10 45 135 310 1,4 AW 110 180 2
20 2 316646F 1 64 1 1 1 0 0 0 0 0 0 0 23 720 10 5 10 15 10 5 10 35 100 820 1 IWPWRV 96 120 2
21 2 *572662 1 70 1 1 0 1 1 0 0 1 0 0 NA 165 7 3 45 15 10 15 10 95 200 365 1,4 IWRV 43 100 2
22 2 359857F 1 53 0 1 1 0 0 0 0 0 0 26.5 195 8 7 40 15 10 10 15 50 155 350 1,4 AW 98 130 1
23 2 364420F 1 54 1 0 0 0 0 0 0 0 0 0 29.4 840 2 8 30 15 15 35 10 45 160 1000 1,3,4 AW 104 140 1
24 2 374012F 1 60 1 1 0 0 0 0 0 0 0 0 23.7 120 9 7 20 10 10 10 15 35 116 336 1,4 AW 96 106 2
25 2 374129F 1 65 0 0 1 0 0 0 0 0 0 0 18.8 140 8 7 35 15 10 5 13 40 133 273 1,4 IWPWRV 76 94 1
26 2 379580F 1 44 0 0 1 0 0 0 0 0 0 0 25.3 80 5 5 20 10 10 10 5 45 110 190 1,4 AW 72 100 1
27 2 379589F 1 57 0 0 1 1 0 0 0 0 0 0 27.3 430 44 5 20 15 10 10 5 70 135 560 1,4 IWPWRV 70 110 1
28 2 379911F 1 52 1 1 1 0 0 0 0 0 0 0 19 280 5 5 15 7 10 38 15 30 125 405 1,2 IWRV 88 70 2
29 2 863593A 2 62 1 1 1 0 0 0 0 0 0 0 24.7 50 5 5 35 5 10 30 35 40 165 205 1,3,4 AW 76 120 1
30 2 379982F 1 62 0 0 0 0 0 0 0 0 0 27.8 1020 5 5 20 10 10 10 10 120 190 1210 1,4 IWPW 80 140 2
31 2 379650F 2 44 1 0 1 0 0 0 0 0 0 0 28 210 8 5 20 7 10 5 10 40 105 315 1,2,4 IWPWRV 54 110 1
32 2 379690F 1 65 0 1 1 1 1 1 0 0 0 0 27.8 1020 8 7 15 10 10 5 10 50 115 1135 1 IWRV 60 100 1
Hosp.no. %STR Arr TPI R/F CAD Culpar pTIMI  Thrasp DES/BMS TIMIp Noncul Pro comp TIMI risk LVEF c.vol  CIN t zone day hosp.o 30d o pay unit
288407F 1 0 0 R SVD LADm 0 1 DES 3 0 0 2 45 150 0 1 6 A A 1 3
287354F 3 1/chb 1 F LM+TVD RCAp 0 1 BMS 3 0 0 6 50 100 0 1 2 A A 1 1
286849F 1 0 0 R SVD LADp 0 1 DES 3 0 0 4 34 150 0 1 5 A A 1 1
295626F 2 1/chb 1 R TVD RCAd 0 1 BMS 3 0 0 3 50 120 0 2 5 A A 1 2
058546F 1 0 0 R SVD LADm 2 0 DES 3 0 0 3 47 130 0 2 3 A A 1 1
327307F 1 0 0 R SVD RCAm 0 1 BMS 3 0 0 2 44 150 0 2 5 A A 3 2
322632F 2 0 0 R DVD RCAd 0 1 DES 3 0 0 3 43 200 0 1 6 A A 1 3
322636F 1 0 0 R SVD LADp 0 1 DES 3 0 0 2 45 200 0 1 6 A A 1 3
322650F 1 0 0 R SVD LCXd 1 0 DES 3 0 0 1 59 200 0 1 6 A A 3 3
168166F 2 0 0 F SVD LADm 0 1 0 3 0 0 3 40 100 0 1 4 A A 5 2
*021711 2 0 0 R SVD LADd 2 0 DES 3 0 0 7 42 200 0 2 4 A A 2 3
331256F 2 1/vtrig 0 R SVD LADp 0 1 DES 3 0 0 3 44 120 0 1 1 A A 1 2
331534F 2 0 0 R SVD LADp 0 1 BMS 2 0 0 2 41 150 0 2 3 A A 3 1
338794F 2 0 0 R SVD LADp 0 1 DES 2 0 0 7 45 200 0 2 2 A A 1 2
338546F 3 0 0 R SVD LADp 0 1 DES 3 0 0 3 33 200 0 1 6 A A 3 3
341764F 2 0 0 R SVD LADp 0 1 DES 3 0 0 6 42 200 0 2 3 A A 1 3
799760D 2 0 0 R DVD LADp 0 1 DES 3 0 0 2 46 200 0 1 2 A A 1 3
558059D 2 qrbbb 0 F DVD LADp 0 1 DES 3 0 0 8 42 150 0 1 1 A A 1 1
411056D 1 0 0 R TVD LADp 0 1 0 3 0 0 7 44 100 0 1 2 A A 3 2
316646F 2 0 0 R TVD RCAp 0 1 DES 3 0 0 5 41 100 0 1 3 A A 1 3
*572662 3 1/chb 1 F DVD RCAd 0 1 BMS 2 0 0 5 30 200 0 2 6 E 0 3 3
359857F 2 0 0 R DVD LADd 0 1 0 3 1/RCA 0 3 42 150 0 2 7 A A 1 3
364420F 2 0 0 R SVD LADP 0 1 BMS 3 0 0 5 43 200 0 1 2 A A 3 3
374012F 3 0 0 R SVD LADm 0 1 DES 2 0 0 5 42 180 0 1 6 A A 1 3
374129F 1 0 0 R TVD RCAm 0 1 BMS 3 0 0 5 52 160 0 1 3 A A 3 3
379580F 1 ,HB1 0 F DVD LADM 0 0 BMS 3 0 1a 5 35 120 0 1 3 A A 3 3
379589F 2 1/qrbbb 0 R SVD LCXd 0 1 DES 3 0 0 5 57 100 0 2 3 A A 4 3
379911F 2 /vpc,1hb,vb 1 F TVD OM1p 0 0 0 3 0 0 8 30 120 0 2 4 A CVA 1 3
863593A 2 1/lbbb 1 F SVD LADp 0 1 DES 3 0 1 3 42 170 1 1 4 A HF 2 1
379982F 2 0 0 R SVD RPLBp 0 0 BMS 3 0 0 3 48 80 1 1 5 A A 3 3
379650F 1 1/JR 1 R SVD RCAp 0 1 BMS 3 0 0 2 53 80 0 1 7 A A 3 3
379690F 2 0 0 R DVD RCAp 0 1 DES 3 0 0 3 48 100 1 2 1 A A 1 3
33 2 032651F 1 71 0 0 1 0 0 0 0 0 0 0 21.9 30 3 5 25 5 5 10 10 42 105 135 1,4 IWPWRV 72 130 1
34 1 280472F 1 64 1 1 1 0 0 0 0 0 0 0 21.4 300 2 6 35 10 5 10 16 0 84 384 0 AW 120 150 2
35 1 291306F 1 65 0 0 0 1 0 0 0 0 0 0 21.3 265 3 7 20 10 5 5 15 0 65 330 0 AW 110 140 1
36 1 256769D 1 60 1 1 0 0 0 0 0 0 1 25.9 180 1 4 25 10 5 10 10 0 65 245 0 LW 68 140 1
37 1 299314F 1 56 1 0 0 1 0 0 0 0 0 0 20.8 240 2 8 20 15 5 10 20 0 80 320 0 IWPW 72 130 1
38 1 299336F 1 82 0 0 0 1 0 0 0 0 0 0 27.5 390 4 6 35 20 10 15 15 0 105 495 4 IWRV 74 110 1
39 1 299330 1 51 1 1 1 0 0 0 0 0 0 0 29.3 180 5 2 38 10 10 10 20 0 95 275 4,5 IWRV 94 130 1
40 1 304077F 1 82 0 1 1 0 1 0 0 0 1 0 26.5 150 1 4 5 20 10 10 15 0 65 215 0 AW 60 130 1
41 1 301441F 1 55 1 0 0 0 1 0 0 0 0 0 27.2 180 3 5 15 5 5 5 15 0 53 233 0 AW 83 130 2
42 1 309665F 1 70 0 0 1 1 0 0 0 0 0 0 17.3 360 5 5 45 20 10 10 35 0 130 490 4,5 AW 120 80 4
43 1 309758F 1 45 1 0 1 1 0 0 0 0 0 0 24.8 420 5 5 25 10 10 5 20 0 80 500 0 AW 78 130 1
44 1 761606D 1 62 1 1 1 1 0 0 0 1 0 0 20.2 220 4 1 25 5 10 5 20 0 70 290 0 IWRV 65 120 1
45 1 318523F 2 66 0 1 1 0 0 0 0 0 0 0 27 300 3 7 15 15 10 15 20 0 85 385 0 LW 110 120 1
46 1 981786A 1 47 0 0 0 0 0 0 0 0 0 0 24.4 220 4 1 40 15 10 35 10 0 115 335 3,4 IWPWRV 88 110 1
47 1 316513F 1 75 0 0 0 1 0 0 0 0 0 0 22 270 8 7 35 10 10 10 20 0 100 370 4,5 IWRV 79 120 1
48 1 316403F 1 48 0 0 0 1 0 0 0 0 0 0 17.2 120 7 3 30 20 10 10 20 0 100 220 4,5 IWPWRV 68 130 1
49 1 316458F 1 50 1 0 0 1 0 0 0 0 0 25.8 210 2 13 25 25 10 10 5 0 90 300 0 AW 115 150 1
50 1 495506C 1 64 1 1 1 1 0 0 0 0 0 0 25 210 5 5 20 20 10 10 20 0 90 300 0 IWPWRV 106 92 3
51 1 327344F 2 82 1 1 0 0 0 0 1 0 0 1 27.7 330 5 5 100 15 15 10 20 0 170 500 4,5 IWPW 110 150 2
52 1 327352F 2 75 1 0 0 0 0 0 0 0 0 0 24.2 135 3 2 25 15 10 15 15 0 85 220 0 IWRV 50 48 1
53 1 171661F 1 49 0 0 1 0 1 0 0 1 0 0 22.6 60 5 2 48 15 10 15 5 0 105 165 4 AW 94 120 1
54 1 3271138F 1 55 0 1 1 0 0 0 0 0 0 0 23.8 1020 5 5 35 20 15 10 10 0 100 1120 4 AW 105 120 1
55 1 327649F 2 70 1 1 0 0 0 0 0 0 0 0 26.7 630 6 4 20 10 10 10 20 0 80 710 0 IWRV 68 122 1
56 1 243289D 1 43 1 0 1 0 0 0 0 0 0 0 31.9 300 5 5 15 10 10 10 10 0 65 365 0 AW 82 140 1
57 1 331180F 1 48 0 1 1 1 0 0 0 0 0 0 23.3 30 6 4 10 20 5 5 10 0 60 90 0 IWRV 72 116 1
58 1 331578F 1 50 1 1 1 1 0 0 0 0 0 1 29.5 60 5 2 18 10 10 10 10 0 65 125 0 AW 70 140 2
59 1 072523A 1 84 1 1 0 0 1 0 0 0 1 0 20.7 120 2 3 15 10 5 10 15 0 60 180 0 LW 136 120 1
60 1 338764F 1 52 0 1 1 0 0 0 0 0 0 0 23.9 630 2 8 30 15 10 10 35 0 110 740 4,5 AW 108 98 3
61 1 726097D 1 61 0 0 1 0 0 0 0 0 0 1 32.7 330 7 3 30 10 10 10 30 0 100 430 4,5 IWRV 88 80 1
62 1 338547F 2 65 0 0 0 0 0 0 0 0 0 0 21.3 340 5 5 15 10 5 10 15 0 65 405 0 IWRV 64 170 1
63 1 347653F 1 45 0 1 1 1 0 0 0 0 0 1 27.1 60 8 2 10 10 10 10 10 0 60 120 0 IWPWRV 56 110 1
64 1 341765F 1 55 0 0 0 1 0 0 0 0 0 0 26.4 975 3 2 30 20 15 10 10 0 90 1065 0 AW 102 130 1
032651F 1 0 0 R DVD RCAd 0 1 BMS 3 0 0 11 50 120 0 1 2 A A 4 1
280472F 1 0 0 R DVD LADp 0 1 DES 3 0 0 8 42 150 0 1 7 A A 1 3
291306F 1 0 0 R SVD LADp 0 1 BMS 3 0 0 7 48 120 0 1 3 A A 3 3
256769D 2 0 0 F TVD D1p 0 0 BMS 2 1/LADm 0 3 42 100 0 1 5 A A 1 2
299314F 1 0 0 R TVD RPLBp 0 0 DES 3 0 0 3 56 200 0 1 1 A A 1 3
299336F 3 0 0 R LM+DVD RCAm 0 1 DES 3 0 0 4 50 200 0 1 1 A A 1 3
299330 2 1/rbbb 0 R SVD RPDAp 2 1 BMS 3 0 0 2 57 170 0 2 1 A A 1 2
304077F 2 0 0 R SVD LADp 0 1 DES 3 0 0 0 52 250 0 1 4 A A 1 2
301441F 2 0 0 R TVD LADp 0 1 DES 3 0 0 4 42 110 0 1 5 A A 1 1
309665F 3 1/qrbb 0 R DVD LADp 0 1 0 3 0 0 12 30 200 1 1 1 ECS 0 1 2
309758F 1 0 0 R SVD LADm 0 1 DES 3 0 0 3 41 200 0 2 2 A A 4 2
761606D 2 0 0 R DVD RCAp 0 1 BMS 3 0 3 52 140 0 1 5 A A 1 2
318523F 2 0 0 R TVD LCXp 1 0 DES 3 1/LAD&RCA 0 9 42 150 0 1 6 A A 2 3
981786A 2 1/chb 0 F LM+TVD RCAd 1 1 0 3 1/LAD,LCX 0 2 51 100 0 1 6 A A 1 3
316513F 1 0 0 R SVD RCAp 0 1 BMS 3 0 0 5 49 100 0 1 1 A A 3 2
316403F 2 1/aivr 0 R LM+DVD RCAm 0 1 BMS 3 0 0 1 41 200 0 1 4 A A 3 2
316458F 1 1/VT 0 R SVD LADp 0 1 DES 3 0 0 5 56 150 0 1 5 A A 1 1
495506C 2 0 0 R TVD RCAp 0 1 BMS 3 0 0 10 37 100 1 2 1 A ExpST 3 1
327344F 3 0 0 R SVD OM1p 0 1 DES 3 0 1a 9 40 200 1 1 6 A ExpST 1 3
327352F 1 1/chb 1 R DVD RCAp 0 1 DES 3 0 0 7 40 100 0 1 6 A A 1 3
171661F 1 0 0 F SVD LADp 0 1 DES 3 0 0 1 41 100 0 1 2 A A 3 1
3271138F 2 1/apc + 0 R SVD LADd 0 1 BMS 3 0 0 5 40 200 0 2 4 A A 4 2
327649F 2 0 0 R DVD RCAm 0 1 BMS 3 0 1b 5 45 100 0 1 6 A A 3 3
243289D 2 0 0 R DVD LADm 2 0 DES 3 0 0 3 45 100 0 2 7 A A 4 3
331180F 1 0 0 R DVD RCAp 0 1 DES 3 0 0 1 56 200 0 1 7 A A 4 3
331578F 1 0 0 R SVD LADm 0 1 DES 3 0 0 4 41 100 0 1 3 A A 4 3
072523A 1 1/af 0 R TVD LCXd 0 0 DES 3 0 0 8 39 100 0 2 4 A A 1 3
338764F 3 1/qrbb 1 F TVD LADp 0 1 0 3 0 0 11 27 100 1 2 1 ECS 0 3 2
726097D 1 0 0 R SVD RCAp 0 1 DES 3 0 0 4 52 200 0 1 1 A A 4 2
338547F 2 0 0 R TVD RCAd 0 0 DES 3 0 0 4 52 250 0 1 1 A A 1 3
347653F 1 1/chb 0 R DVD RCAp 0 1 DES 3 0 0 0 47 300 0 1 5 A A 1 2
341765F 2 0 0 R SVD LADp 0 1 BMS 3 0 0 4 43 200 1 2 5 A A 3 3
65 1 347566F 2 60 1 0 1 0 0 0 0 0 0 0 28.8 290 1 4 15 5 5 30 5 0 65 355 0 AW 65 130 1
66 1 347675F 2 45 0 0 0 0 0 0 0 0 0 0 18.1 90 3 7 25 15 10 10 15 0 85 175 0 IWRV 96 150 1
67 1 347689F 1 57 0 1 0 0 0 0 0 0 0 0 25.9 225 3 7 20 10 10 5 15 0 70 295 0 AW 80 100 1
68 1 151851F 1 61 0 1 0 1 0 0 0 0 0 0 19.9 250 5 5 30 20 10 10 10 0 90 340 0 IWPWRV 70 110 1
69 1 354474F 1 59 1 1 0 0 0 0 0 0 0 0 21.8 300 2 3 15 15 10 10 10 0 65 365 0 IWPWRV 120 150 1
70 1 354631F 1 60 1 1 0 0 1 0 0 0 0 1 21.9 300 6 4 35 10 15 10 20 0 100 400 4,5 IWPWRV 80 120 1
71 1 354644F 2 48 1 1 0 0 0 0 0 0 0 26.8 90 3 7 25 20 15 10 10 0 90 180 0 AW 80 130 1
72 1 354675F 1 61 0 0 0 0 0 0 0 0 0 0 22.7 480 2 8 25 10 10 10 15 0 80 560 0 AW 64 90 1
73 1 354805F 1 44 0 0 0 1 0 0 0 0 0 1 26.6 155 3 2 10 10 5 10 15 0 55 210 0 IWPWRV 74 130 1
74 1 355313F 1 40 1 0 0 1 0 0 0 0 0 0 22.6 230 2 8 30 20 10 5 10 0 85 315 0 AW 90 156 1
75 1 139673D 1 42 0 1 1 0 1 0 0 0 0 0 23.7 200 6 5 30 15 10 10 10 0 86 286 0 AW 102 140 1
76 1 354873F 1 54 1 1 1 0 1 0 0 0 0 0 20.2 230 3 7 15 10 10 5 10 0 60 290 0 AW 140 170 3
77 1 359638F 2 65 0 1 1 0 0 0 0 0 0 0 25.2 330 2 3 35 20 10 10 25 0 105 440 4,5 AW 103 130 3
78 1 382777D 1 75 1 1 1 0 0 0 0 0 0 0 21.6 280 4 1 5 15 10 10 5 0 50 330 0 IWRV 50 80 1
79 1 359694F 2 78 0 0 1 0 0 0 0 0 0 0 19 180 3 7 15 15 10 10 20 0 80 260 0 AW 96 120 1
80 1 307624F 1 48 1 1 1 0 1 0 0 0 0 0 30.5 60 7 5 25 15 15 5 10 0 82 142 0 AW 84 120 1
81 1 364416F 1 61 0 1 1 0 0 0 0 0 0 0 33.6 120 4 1 25 28 45 5 10 0 118 338 2,3,4 IWRV 72 130 1
82 1 364531F 1 54 0 1 1 1 0 0 0 0 0 0 27.7 75 3 2 15 12 10 10 15 0 67 142 0 IWRV 58 100 1
83 1 364538F 1 44 0 1 1 1 0 0 0 0 0 1 25.9 1260 5 5 25 15 10 10 20 0 90 1350 0 IWPW 82 130 1
84 1 367771F 1 74 1 0 1 0 0 0 0 0 0 0 27.3 75 1 80 5 10 10 10 10 0 126 200 6 AW 80 110 1
85 1 374038F 1 82 1 0 0 0 0 0 0 0 0 0 20.2 210 2 3 25 15 15 5 26 0 91 301 4,5 AW 80 150 1
86 1 374341F 1 61 1 1 1 0 0 0 0 0 0 0 27.7 230 5 5 25 10 10 10 20 0 85 315 0 IWPW 66 110 1
87 1 362711F 1 83 1 0 1 1 0 0 0 0 1 0 21.1 220 2 3 30 10 10 15 23 0 93 313 4,5 AW 80 110 2
88 1 379927F 1 56 0 0 1 1 1 0 0 0 0 0 24.6 56 4 5 5 20 15 40 10 0 99 155 3 AW 82 160 1
89 1 379937F 1 39 0 0 1 1 0 0 0 0 0 0 29.7 170 3 7 30 20 15 10 15 0 100 270 4 IW 84 140 1
90 1 222372F 1 49 0 0 1 1 0 0 0 0 0 0 20.3 885 3 5 15 10 5 9 16 0 63 948 0 AW 78 120 1
91 1 379825F 1 39 1 0 1 0 0 0 0 0 0 0 24.2 325 4 6 45 20 5 15 32 0 127 452 4,5 IWRV 62 120 1
92 1 509837F 1 63 1 1 1 0 1 0 0 0 0 0 22.4 960 3 2 20 10 10 15 8 0 68 1028 0 IWPWRV 99 110 1
93 1 384097F 1 50 1 1 1 0 0 0 0 0 0 0 24.2 270 5 5 29 15 10 10 20 0 94 364 4,5 AW 98 100 1
94 1 107899A 1 47 0 0 1 0 0 0 0 0 0 0 20.1 70 1 4 10 22 13 5 6 0 61 131 0 AW 64 110 1
95 1 474218F 1 37 0 1 0 1 0 0 0 0 0 0 22.5 58 5 4 20 11 4 5 9 0 58 116 0 IWPWRV 55 100 1
96 1 474296F 1 56 0 1 0 0 0 0 0 0 0 0 25.9 300 3 2 23 10 10 6 20 0 74 374 0 IWRV 110 130 1
347566F 2 1/Vbig 0 R DVD LADm 2 0 DES 3 0 0 4 52 150 0 1 4 A A 1 3
347675F 1 0 0 R DVD LCXp 2 0 BMS 3 0 0 1 48 50 0 1 5 A A 3 2
347689F 2 0 0 R SVD LADp 0 1 DES 3 0 0 3 54 50 0 1 5 A A 1 3
151851F 1 0 0 R SVD RCAp 0 1 DES 3 0 0 1 50 100 0 1 1 A A 3 3
354474F 2 0 0 R LM+DVD RCAd 0 1 0 3 0 0 4 55 200 0 2 1 A A 1 3
354631F 2 0 0 R DVD RCAm 0 0 DES 3 0 0 2 43 200 0 1 3 A A 1 2
354644F 2 0 0 R SVD LADm 0 1 DES 3 0 0 4 48 100 0 2 3 A A 1 2
354675F 2 0 0 R SVD LADp 0 1 DES 3 0 0 6 52 100 0 1 4 A A 1 3
354805F 1 1/1HB 0 R DVD RCAp 0 1 DES 3 0 0 0 53 150 0 2 6 A A 1 2
355313F 2 0 0 R SVD LADp 0 1 DES 3 0 0 3 43 150 0 1 7 A A 3 3
139673D 2 0 0 R TVD LADd 0 1 DES 3 0 0 5 41 100 0 1 2 A A 1 3
354873F 2 0 0 R DVD LADd 2 1 BMS 3 0 0 8 21 100 0 2 3 A A 3 2
359638F 3 1/chb 1 F TVD LADp 1 1 BMS 2 0 0 9 32 100 1 2 1 ECS 0 1 2
382777D 1 1/chb 1 F TVD RCAm 0 1 DES 3 0 0 8 44 100 0 1 5 A A 1 1
359694F 1 0 0 R DVD LADp 0 1 DES 3 0 0 4 36 100 1 1 6 A A 1 2
307624F 1 0 0 R SVD LADp 0 1 DES 3 0 0 2 44 100 0 1 7 A A 1 1
364416F 1 1/VT 0 R SVD RCAm 0 1 DES 3 0 0 1 56 100 0 1 2 A A 1 3
364531F 1 0 0 R DVD RCAd 1 1 BMS 2 0 0 1 54 100 0 1 3 A A 4 2
364538F 1 0 0 R DVD OM1p 1 1 DES 3 0 0 3 58 100 0 1 3 A A 4 2
367771F 1 0 0 R SVD LADd 0 1 DES 3 0 0 4 46 100 0 2 4 A A 1 2
374038F 2 0 0 R TVD LADm 0 1 DES 3 0 0 2 45 150 0 1 7 A A 1 2
374341F 2 0 0 R DVD RCAm 2 1 DES 3 0 0 2 56 180 0 1 4 A A 1 2
362711F 2 0 0 RF SVD LADp 1 1 DES 3 0 0 9 38 150 0 2 1 A A 1 3
379927F 1 0 0 R SVD LADm 0 1 DES 3 0 0 3 42 180 0 1 4 A A 1 1
379937F 1 0 0 R DVD RCAp 0 1 BMS 3 0 0 1 45 150 0 1 4 A A 1 2
222372F 3 1/qrbb 0 R DVD LADp 0 1 BMS 3 0 0 3 41 100 1 2 7 A A 3 1
379825F 2 0 0 R TVD RCAm 0 1 BMS 3 0 0 1 45 350 0 1 1 A A 1 2
509837F 2 0 0 R LM+TVD RCAd 0 0 0 3 0 0 3 47 200 1 1 1 A A 1 2
384097F 2 0 0 R SVD LADp 0 1 BMS 3 0 0 3 43 80 0 2 4 A A 3 3
107899A 1 1/VT 0 R DVD LADp 0 1 DES 3 0 0 2 46 100 0 2 7 A A 2 1
474218F 2 1/chb.-->VT 1 R SVD RCAm 0 1 DES 3 0 0 1 44 100 0 1 7 A A 1 1
474296F 2 0 0 R TVD RCAm 1 1 DES 3 0 0 1 51 100 0 2 3 A A 1 1
